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Background: Illness in athletes is an inevitable part of participation in sports, and can 
significantly interfere with training, during tournaments or at competition time. The incidence of 
illness in sports varies in different sporting codes and across different tournaments and 
competitions. The Super Rugby competition is a particularly demanding 16-week tournament 
among countries in the Southern Hemisphere, and is associated with a high incidence of illness. In 
this tournament, 15 rugby union teams compete and play international level matches every week, 
which involves travel across numerous time zones and therefore may be associated with a higher 
incidence of illness in players. 
Objective: The main objectives of this dissertation were to 1) review the epidemiology and risk 
factors for illness in athletes participating in tournaments or competitions, and 2) determine which 
intrinsic risk factors predispose players to illness during the 2010 Super Rugby tournament. 
Methods: This dissertation consisted of two main phases. In phase I, a systematic review of the 
literature was undertaken, using evidence-based criteria, to determine which risk factors 
predispose athletes to illness during tournaments. In phase II, a prospective cohort research study 
was undertaken, involving 239 players from South Africa and New Zealand, over the 16-week 
duration of the 2010 Super 14 Rugby Union tournament. For phase II, a pre-season medical 
questionnaire was administered to determine baseline medical data. Collection of data then took 
place each day of the competition, beginning 7 days before the first game the team played, and 
ending when each team played their final game. Each team physician completed a daily "medical 
illness log" for every player. Booklets were supplied that contained daily illness report forms.  
Results: The main findings of the review (phase I) were good evidence (level I and II) indicating 
that 1) international travel, and the duration of a tournament are extrinsic risk factors for illness in 
athletes, and 2) that prolonged and high intensity training, older age, and nutritional deficiencies 
are intrinsic risk factors for illness in athletes. The main findings of the prospective cohort study 
(phase II)  were that an increased number of training days in the 2 weeks before the tournament 
was an independent risk factor for any illness, respiratory system illness, and digestive system 
illness; the % time spent on endurance training in the 15 weeks before the tournament was an 




inflammatory medication was an independent risk factor associated with respiratory system 
illness. 
 
Summary and conclusion: In summary, novel intrinsic risk factors for illness in rugby players 
participating in the Super Rugby tournament were training more days/hours per week in the 2 
weeks before the tournament, as well as endurance-type training 15 weeks before the tournament. 
These data can form the basis of planning preventative strategies to reduce the risk of illness in 
the Super Rugby tournament.  
 






Introduction and scope of the thesis 
 
Injuries and illnesses are an inevitable part of sports participation. Athletes, although normally fit 
and healthy, are just as susceptible to illness as the general population. In fact, there is evidence 
[1] to suggest that during periods of high intensity training or prolonged endurance-type training, 
that athletes for a brief period up to 72 hours may have a temporarily depressed immune system 
and hence may in fact be more susceptible to illness.  
 
The International Olympic Committee (IOC) [2] and other sporting bodies, have increasingly 
recognized that illness is an important component of athlete medical care. In recent years, there 
have been more studies documenting the incidence and risk factors for illness in athletes 
participating in tournaments and competitions. Protecting the health of the Olympic athlete is the 
highest priority of the International Olympic Committee (IOC) Medical Commission [3] resulting 
in an increase in the allocation of resources to injury and illness surveillance and the prevention of 
adverse health events.  
 
Elite athletes are frequently required to travel long distances for major competitions [4]. The 
modern day athlete frequently attends training camps away from their home country, and may 
participate in multiple tournaments in a calendar year. The duration of these tournaments may 
vary form days to weeks. Despite the improved fitness and conditioning of athletes, the most 
common reason to miss training or competition, whilst abroad, is illness [5]. Illness significantly 
affects athletes, coaches and medical teams, and can result in loss of time during periods of 
conditioning and preparation. More importantly, illness can result in the inability to compete and 
therefore detract from the many hours of preparation for competitions. Therefore, appropriate 






Rugby Union is one of the world’s most physically demanding contact team sports. It is played in 
numerous countries around the world, and is also one of South Africa’s most popular professional 
team sports. While rugby injuries have been well documented, the incidence of illnesses in rugby 
players is not as well documented. 
 
The Super Rugby tournament is a 16-week, annual tournament held in the southern hemisphere. It 
was introduced in 1996 and was the first fully professional rugby tournament at that time, 
involving 10 teams. Its popularity grew over the years and has now expanded to involve 15 teams 
from the southern hemisphere. The tournament is played over a 4-month period in the first half of 
the year between teams from South Africa, Australia and New Zealand. Teams play most 
weekends for the duration of the 16-week tournament. The competition is generally regarded as 
one of the most demanding rugby competitions in the world, placing exceptional physical and 
emotional stresses on the players. Furthermore, teams have to travel across multiple time zones as 
matches are played in venues in all three countries, resulting in very demanding travel schedules. 
This exposes players to different allergens and pathogenic organisms, as well as climatic changes, 
environmental conditions and differing diets. 
 
In a study conducted during the 2010 Super Rugby tournament, it was found that the incidence of 
illness was 20.7/1000 player days, and was highest in the respiratory system (30.9%) followed by 
the digestive system (27.5%) [7]. This is consistent with the findings of other illness studies 
during competitions. It was also recorded that infections accounted for 54.5% of all illness and 
26.1% of illness resulted in time loss of ≥1 day. In over 50% of illnesses, symptoms were present 
for ≥1 day before being reported to the team physician. To date, there are only a few studies 
where the true incidence of illness (illness per 1000 athlete days) in elite athletes during 
tournaments has been reported. This makes comparison to other studies where incidence is 
measured per 1000 athletes difficult. 
 
As this tournament appears to be associated with a high incidence of illness, the aim of this 
dissertation was to explore the intrinsic risk factors associated with illness in eight of the 14 Super 




competition. These risk factors related to: a detailed training history; medication and supplement 
use; lifestyle factors, such as smoking and alcohol; a family history of asthma or allergies; 
immunization history; the player’s medical history of current asthma, allergies, recent flu-like 
illness and close contact with individuals with flu-like illness. 
 
An understanding of the epidemiology of illness and the possible intrinsic (player specific) risk 
factors contributing to illness in the two main systems affected by illness could assist medical 
personnel and coaching staff to minimize these risk factors in certain players or the team in 
general. This could result in a lower incidence of illness and hence a healthier squad of players for 




















A review of the epidemiology and risk factors for illness in athletes 
participating in sport tournaments or competitions – a specific focus 





In the modern-day sports calendar, competitions and tournaments are scheduled throughout the 
year in many countries and continents. The modern-day athlete frequently attends training camps 
away from their home country, and may participate in multiple national and international 
tournaments in a calendar year. The duration of these tournaments may vary form days to weeks. 
The physical and psychological demands on athletes are not only those related to training and 
competition, but in modern day sport include travel, living in confined conditions, sharing rooms, 
and exposure to differing environmental conditions. These demands may increase the risk of 
illness, which does not only increase the risk of medical complications during exercise but can 
also negatively affect athletic performance. As a result, there has been a growing recognition of 
the importance to protect the health of athletes. This has resulted in an increasing need for 
research to determine the risk of illness, patterns of illness and to identify the risk factors for 
illness. This information is essential to develop preventative measures to combat the risk of illness 
and protect the health of the athlete. 
 
Rugby Union is one of the world’s most physically demanding contact team sports. It is played in 
numerous countries around the world, and is also one of South Africa’s most popular professional 
team sports. Repetitive body contact and impact during both matches and contact training sessions 
results in a well-documented high incidence of injuries in rugby, when compared to other sports. 
In a recent meta-analysis it was reported that match injury incidence rates in professional Rugby 
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Union are high in comparison with other team sports [8]. While the epidemiology and risk factors 
associated with rugby injuries have been well documented, similar data on illnesses in rugby 
players is not readily available. Indeed, we are aware of only two research studies where the focus 
has been on protecting the health of the rugby player [7, 9]. 
The Super Rugby tournament is a 16-week, annual tournament held in the southern hemisphere. 
In the 2010 Super 14 tournament, 14 international rugby teams took part in the tournament, which 
was held at different venues in South Africa, Australia and New Zealand and took place between 
February and May 2010. This annual Super Rugby competition is unique in that it is played over a 
long period of time (16 weeks) and it is held in 3 different countries. Therefore, unlike most other 
sports tournaments that are normally held in one country, at a single venue and over a shorter 
period of time, this tournament requires frequent international travel across multiple time zones 
for a period over a number of weeks. The exposure to a number of foreign destinations results in 
players being exposed to different allergens and pathogenic organisms, not to mention climatic 
changes, environmental conditions and differing diets. The effect that traveling across different 
time zones may have on illness risk in players has been studied [10].  
The focus of this review is to describe the epidemiology of illness in athletes during various sports 
tournaments, followed by a specific focus on rugby, where these data are available. The review 
will then explore the risk factors that are associated with illness in athletes participating in sports 
tournaments.  
2.2. Definitions and terminology 
For the purposes of this review and this dissertation, standardized definitions and epidemiological 
terms, which have been used in other studies to express the burden of illness in athletes 
participating in competitions or tournaments, will be used as follows: 
- Illness: An illness is defined as ‘any non-trauma related symptom or sign presenting in a player
that required medical attention from the team physician on a specific day’ [7]. A repeat illness is




within 7 days’ [7], and a time-loss illness is defined as ‘an illness resulting in one or more lost 
training or match days’ [7].- Incidence: The incidence of illness is defined as the number of 
illnesses reported per 1000 player days [11] [12] [13].  
- Incidence Proportion (IP): The incidence proportion is defined as the proportion of athletes 
reporting an illness during a tournament. This can be expressed as % athletes with illness or 
athletes with illness per 1000 athletes at the tournament [14] [15] [16] [17] [18] [19] [20].  
 
- Prevalence: The prevalence is defined as the percentage of a population that is affected with a 
particular illness at a given time. 
 
2.3. Epidemiology of all illnesses in elite athletes during tournaments 
 
Until recently, the epidemiology and nature of medical illness in elite athletes has not been well 
studied. However, the International Olympic Committee (IOC) [2] and other sporting bodies, have 
increasingly recognized that illness is an important component of athlete medical care. In recent 
years, there have been more studies documenting the incidence and risk factors for illness in 
athletes participating in tournaments and competitions. Protection of the health of the athlete is 
now recognized as a very important component of holistic athlete care, and since 2007, the 
International Olympic Committee (IOC) has been developing various programs for the prevention 
of injuries and diseases in high level and recreational sports. This development is also taking 
place within International Federations (IFs) such as the Fédération Internationale de Football 
Association (FIFA), the International Ice Hockey Federation (IIHF), the International Association 
of Athletics Federations (IAAF) and the Federation Internationale de Natation Aquatics (FINA), 
as well as with renowned research institutions worldwide [3]. In the majority of the recently 
published studies, illness has been reported as an illness proportion (IP) rather than a true 
incidence (per 1000 athlete days of exposure) of illness.  
 
In one of the earliest prospective studies, newly incurred illnesses were recorded at the 2009 
International Association of Athletics Federation (IAAF) World Championship. In this study, the 




prospective study conducted during the 2011 Daegu IAAF Championship, where the IP was 68.1 
illnesses per 1000 registered athletes [15]. These IP’s are similar to those reported during the 2009 
Federation Internationale de Natation Aquatics (FINA) competition (70.0 per 1000 registered 
athletes) [14], the London 2012 Summer Olympic Games (71.7 per 1000 registered athletes) [17] 
as well as the 2010 Winter Olympics (72.1 per 1000 registered athletes) [19]. However, in the 18-
day 2014 Sochi Winter Olympic Games the IP was higher (89 per 1000 registered athletes) [20], 
and this was even higher at the second Asian Beach Games involving 14 different beach sports, 
where the incidence of illness was reported as 104.2 per 1000 registered athletes [18]. It should be 
noted that a significant limitation of reporting IP only in tournaments is that the length of the 
tournament (exposure days) can affect the IP. Therefore, reporting the incidence per 1000 athlete 
day exposure is more accurate, and allows for a true comparison between the incidences of illness 
in tournaments.   
 
To date, there are only a few studies where the true incidence of illness (illness per 1000 athlete 
days) in elite athletes during tournaments has been reported. The true incidence of illness was first 
reported during the 2-week 2009 Confederations Cup Football tournament. In this study the 
incidence of illness was 16.9/1000 player days [13]. This was followed by a study conducted 
during the 4-week 2010 Federation Internationale de Football Association (FIFA) World Cup 
tournament where the incidence of illness was reported as 7.7/1000 player days [11]. At the 2012 
Summer Paralympic Games, the incidence of illness was also studied. In this population of 
athletes the incidence of illness was reported as 12.8 per 1000 athlete days [12]. 
 
Therefore, it can be deduced that the incidence of illness in elite athletes is clinically significant, 
and warrants closer detection, monitoring, reporting and management. Illness plays a significant 
role in the performance of an athlete in- and out of- competition and presents an important 
challenge to the medical team and the coaching staff alike.  
 
It was noted in all of the illness studies documented above, that the most common system affected 




[20] [18] [11] [12] [21]. The epidemiology of illness in these two systems will be examined in 
further detail in this literature review, and this dissertation. 
 
2.4. Epidemiology of all illness in rugby players participating in a tournament 
 
The epidemiology of illness in Rugby Union players during a season or during a competition has 
not been well studied [7]. In a review of the literature, only two studies on the epidemiology of 
illness in rugby players could be identified. In the first study, the incidence of illness in a group of 
30 rugby players was documented over a 48-week period [9]. The main results were that 123 
upper respiratory infections (URI) were recorded (incidence of four URI episodes per player over 
the period) and 25 digestive system complaints were recorded (0.8 per player over the period).  
 
In a more recent study during the 16-week 2010 Super 14 Rugby tournament, the incidence of 
illness (per 1000 player days) was reported. Unlike other tournaments, which typically take place 
in one venue or in one country, this tournament is unique in that a) players travelled between 
South Africa, New Zealand and Australia over a 16-week period [7], b) the tournament is 
characterized by periods of play in the home country and periods of playing abroad where time 
zone differences vary from 2-11 hours [10], c) this tournament is an event that is characterized by 
very high intensity international standard rugby games [7] on 15 weekends over the 16-week 
period, with an addition of 3-5 training sessions per week. The tournament is also longer than 
most tournaments. The incidence of illness during this tournament was 20.7/1000 player days 
(95% CI 18.5 to 23.5), and this was higher when compared with the incidence of illness reported 
in the 2009 Confederation Cup football tournament (16.9/1000 player days) [13], the 2010 FIFA 
World Cup study in football players (7.7/1000 player days) [11] and during the 2012 London 
Paralympic Games (12.8 per 1000 athlete days) [12]. 
 
The reasons for this higher incidence of illness [7] could be attributed to a number of different 
factors including the following: a possible difference in risk of illness in different sports, a 
different pre-tournament player illness profile; travel differences (e.g. north-south vs. east-west 




pathogenic organisms; differing environmental conditions (temperature, humidity, pollution); and 
variation in diets.  
In both the studies in rugby players, the pattern of illness was similar. In the Super Rugby study, 
the most frequent illness was in the respiratory system (30.9%) (6.4: 95% CI 5.5 to 7.3) followed 
by the digestive system (27.5%) (5.6: 95% CI 4.9 to 6.6%) [7]. In this study, infection was 
recorded as the most common diagnosis, and infections accounted for 54% of all illness. These 
data are very similar to data on the pattern of illness in other individual and multi-coded 
tournaments. In all these studies, illness patterns are very consistent and show a high incidence of 
respiratory tract and gastrointestinal tract illness [14] [11] [19] [16]. Therefore, the epidemiology 
of illness in these two main systems will now be reviewed in more detail.  
 
2.5. Epidemiology of illness in elite athletes during tournaments by system affected 
 
As mentioned, respiratory and digestive system illnesses were consistently reported as the most 
common and second most common illnesses during sports tournaments.  
 
2.5.1. Epidemiology of respiratory illness in elite athletes during tournaments 
 
Elite athletes frequently report respiratory symptoms. Symptoms suggestive of Upper Respiratory 
Tract Infection (URTI) are responsible for 30 to 40% of visits to sports medicine clinics by elite 
athletes [22]. Evidence from several cross-sectional and prospective studies suggests that many 
elite and highly trained athletes experience more common colds or URTI than recreational 
athletes [23-25]. Athletes, especially in team sports, could be at a higher risk of illness and this 
could be due to factors such as the amount of time spent with each other in close proximity, the 
travel to different climates [10], and the potential temporary suppression in immune system 
function after high intensity exercise. 
 
Acute upper respiratory tract (URT) illness was consistently reported as the most common 




and infection was ranked as the leading cause of respiratory tract illness [7, 12] [19, 20] [27] [28]. 
The impact of URI on selected pulmonary, cardiac and skeletal muscle functions may lead to 
illness complications and protracted courses of URI in athletes. Sport performance during illness 
may also decline [29]. Although there has been substantial research in the field of exercise 
immunology and infection during the last two decades, the actual pathogenic causes of symptoms 
of upper respiratory illness in athletes have not been clearly elucidated [30].  
 
The incidence of illness during the 2010 Vancouver Winter Olympics was 72.1 illnesses per 1000 
athletes, and of these illnesses, 62.3% affected the respiratory system [19]. The majority (63.8%) 
of these illnesses were as a result of infection. A study conducted during the 2010 FIFA World 
Cup reported 135 illnesses per 1000 players, with the majority of illnesses affecting the 
respiratory system (40.4%) and the most frequent diagnosis being acute upper respiratory tract 
infection (31.3%) [11]. Again, the cause of most illnesses was reported as infection in the 
majority of cases (60.6% of all illness). 
 
In the 2010 Super 14 Rugby study, the most common system affected was also the respiratory 
system (30.9%), with the most common cause of illness being infection (58.7%) [7]. Of these, 
15.9% were diagnosed specifically as acute Upper Respiratory Tract Infection (URTI). Similar 
data were reported in the 2009 FINA aquatics World Championships, where 50.3% of the 184 
acute illnesses were of the respiratory system with infection most frequently classified as the 
cause (49.2%) [14]. At the London 2012 Summer Olympic Games it was documented that 
respiratory system illness was common (41% of the 310 reported illnesses) with the most 
common cause reported as infection (46%) [17]. These findings are also consistent with 
prevalence data from previous Olympic Games held in in 1996, 2000 and 2004 [17, 31, 32]. 
 
In two studies in athletics, similar data were reported. The 2009 IAAF World Athletics 
Championships reported 135 illnesses with upper respiratory tract infection ranking as the most 
common condition at 30.4%, and infection the most frequent cause (32.6%) [16]. Similarly, the 
Daegu 2011 IAAF Championships study reported 126 illnesses with more than a third (38.9%) 
affecting the upper respiratory tract (including ear, nose and throat) [15]. Again, infection was the 
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most commonly reported cause at 27.8%. When reviewing a different sporting code, that of elite 
yacht racing, again it was consistently reported that URTI accounted for most illness related 
conditions (40%), which also accounted for most days absent from sailing (61%) and training 
(57%) [27].  
In a 5-month prospective surveillance study conducted at the Australian Institute of Sport (AIS) 
on 32 elite and 31 recreationally competitive triathletes and cyclists, and 20 sedentary controls, it 
was reported that pathogens were isolated in fewer than 30% of URI cases [30]. Almost three 
quarters of the participants who reported an upper respiratory illness (URI) episode tested 
negative for detectable infectious agents by microscopy, culture, Polymerase Chain Reaction 
(PCR), and serological testing [30]. The authors concluded that further study is required to 
uncover the causes of unidentified but symptomatic URI in athletes. 
Despite the consistent evidence that there is a high incidence of respiratory tract illness in athletes 
during tournaments, there are minimal data on the risk factors for Respiratory Tract Illness (RTI) 
in these athletes. There is a clear need for better understanding of the aetiology and risk factors of 
URTI in elite athletes, and of the diagnostic and treatment difficulties faced by physicians who 
deal with athletes presenting with upper respiratory symptoms during periods of intensive training 
and competition [30]. It is the loss of training and playing days that will be important to coaches 
and players alike. Being the most prevalent illness, it is therefore imperative that specific 
preventative measures be implemented to minimize the athlete’s risk of developing a respiratory 
system illness. The most effective way of attempting this is to continue to research the aetiology 
and risk factors of such illnesses in athletes.  
2.5.2. Epidemiology of digestive system illnesses in elite athletes during tournaments 
There are some data from several epidemiological studies that digestive system illness is also 
common in athletes, and poses a major threat, not only to athlete’s performance, but also to the 




when considering team sports. Digestive system illness consistently ranks as the second most 
common system affected by illness in elite athletes [6, 7, 11, 12, 14, 15, 19].  
 
In a prospective study of illness during the 2010 Super 14 Rugby Union tournament, the second 
most commonly affected system was the digestive system (27.5%) [7]. Furthermore, the most 
common specific diagnosis was that of gastroenteritis 19.8% (infective and non-infective). 
Digestive tract illness, more specifically gastroenteritis, resulted in the most time-loss illnesses 
(47.3%) [7]. This was also documented in an analysis of 126 illnesses incurred during the 2011 
Daegu IAAF Championships, where gastroenteritis again was recorded as the leading cause of 
time-loss illnesses (6 out of 23 illness episodes; 26.1%) [15].  
 
The digestive system was the most commonly affected system during the 2013 FINA World 
Championships [33]. In a prospective study of newly incurred illnesses in 2592 athletes 
competing at the 2009 FINA World Championships (aquatics), almost a fifth of all 184 illnesses 
reported affected the digestive system (19.9%)[14]. This is similar to findings from a prospective 
study using data from the 2010 FIFA World Cup, which reported 99 illnesses in the 89 football 
players, of which 26 illness episodes (26.3%) related to the digestive system. The second most 
common diagnosis was gastroenteritis (21.2%)[11]. It has also been documented in an illness 
surveillance study of 2567 elite athletes across different sporting codes at the 2010 Winter 
Olympic Games, that 20% of illness was in the digestive system (36 out of 185 illnesses) [19]. An 
IP of 20% of Travellers’ Diarrhoea (TD) was also reported by Team England during the Youth 
Commonwealth Games in India in 2008 [34]. 
 
With the improved fitness and conditioning of athletes, the most common reason to miss training 
or competition, whilst abroad, is illness; especially Traveller’s Diarrhoea (TD) with an athlete 
potentially unable to compete for up to 3 days and after that not performing at an optimum level 
for several more days [5]. In a report detailing the most pertinent medical issues related to the 
travelling athlete to the 1998 Malaysian Commonwealth Games, it was suggested that most cases 
of Traveller’s Diarrhoea (TD) are due to non-viral pathogens such as enterotoxigenic Escherichia 




Traveller’s Diarrhea was reported in hockey players travelling to South Africa, India and 
Malaysia where it was suggested that not only food, but unclean water both in the showers and on 
the pitch resulted in digestive system illness [5]. 
 
The incidence (illnesses per athlete day exposure) of digestive system illness at the 2012 London 
Paralympic Games was 1.90/1000 athlete days [12]. This was equivalent to an Incidence 
Proportion (IP) (percentage of athletes with illness) of 14.5% of all illnesses during both the pre-
competition (3 days) and competition period (11 days). This study was a component of a large 
prospective cohort study on the epidemiology of illness in 3565 elite Paralympic athletes at the 
2012 Games [12]. A slightly higher incidence rate (5.2/1000 athlete days) of digestive system 
illness was recorded in the Polish team at the same Games [6]. This same team (Polish team) 
documented an IR of 3.1/1000 athlete days at the 2008 Beijing Paralympic Games. 
 
In summary, digestive system illness also commonly affects elite athletes and there is a need to 
determine potential risk factors for digestive system illness, which may then identify measures to 
reduce the risk and improve treatment. 
 
2.6. Risk factors for illness in elite athletes during tournaments 
 
Risk factors for illness can be classified as extrinsic risk factors and intrinsic risk factors. 
Extrinsic risk factors refer to factors that are outside of the control of the player, for example 
hotels or environmental conditions. Intrinsic risk factors are factors that are inherent to a player, 
and may be modifiable (for example training and nutrition), or non-modifiable (age and sex). 
While there are numerous studies and scholarly articles describing the extrinsic and intrinsic risk 
factors related to risk of sports injuries, there are very few epidemiological studies to determine 
the risk factors for illness in elite athletes, or in sport in general. In the next section, the extrinsic 
and intrinsic risk factors for illness in athletes will be reviewed. 
 





2.6.1.1. International travel 
 
A high proportion of international travellers experience health problems [36]. The unprecedented 
scale and speed of contemporary international travel means that ever-increasing numbers of 
travellers are exposed to unfamiliar environments and other hazards [37]. Air travel, cramped 
living conditions, changes in diet, differing environmental conditions (such as temperature, 
humidity, atmospheric pollution and altitude), exposure to different allergens and pathogens as 
well as high training and competition loads during travelling may all contribute to an increased 
risk of illness in the travelling athlete [35].  
 
 
In modern sport, elite athletes are frequently required to travel long distances for major 
competitions [4]. There is some evidence that international travel predisposes individuals to 
common infections including influenza and gastro-intestinal illness [38]. However, there are few 
published studies reporting illness in travelling athletes, and indeed few prospective studies in the 
travel medicine literature for comparison. More research is needed to determine the precise 
incidence of illness in travelling athletes from other sporting codes, other tournaments, different 
travel durations, travel destinations and travel direction (e.g., north–south compared with east–
west) [10]. International travel often places athletes at a greater risk of failing to meet their 
specific nutrition goals or succumbing to illness, at a time when the demands or outcomes of 
performance are of greatest importance [39]. 
 
In one prospective cohort study, conducted over a 16-week period during the 2010 Super 14 
Rugby Union tournament, it was reported that international travel to a foreign destination greater 
than 5-hours time zone difference from the home country was associated with a significant 
increase (2-3 times) in the incidence of all illness [10]. Players travelled to South Africa, New 
Zealand or Australia from their home country (which was one of the 3 countries mentioned), at 
least once and sometimes twice or even three times during the 16 weeks. It was further reported 
that the incidence of illness was not affected by the direction of international travel (easterly or 
westerly direction) [10]. Furthermore, travelling back to the home country was not associated with 






It was also suggested by the authors of this particular study that factors such as close contact with 
fellow air travellers, drying of respiratory epithelium and exposure to re-circulated air [10], may 
not be significant factors in the aetiology of respiratory system illness. The reason for this 
conclusion was that a similar incidence of respiratory system illness was documented in both 
directions of travel; however there was only an increased incidence when the athletes departed 
from their home country. This was the first prospective cohort study to determine the effect of 
international travel on the incidence of illness in elite athletes participating in a prolonged 
tournament.  
 
2.6.1.2. Athlete accommodation  
 
During sport competitions, it is common practice that players or athletes share rooms in hotels or 
Olympic villages or at training camps or venues, especially in team sports. Living in such close 
proximity to one another is a possible risk factor for the spread of illness. In a study of over 300 
sailors during the amateur British Telecom Round the World Yacht Race which took place 
between 1996-1997, it was reported that respiratory illness, particularly upper respiratory viral 
type infections, were the third most common and may have spread as result of close quarter living 
conditions [40].  
 
In a study that documented the efficacy of an illness prevention program for Norwegian athletes 
during the 2010 Vancouver Winter Olympics, one of the interventional strategies implemented 
was that athletes with a heavy competition load, or with a susceptibility to respiratory tract 
infections and airway problems, were accommodated for the most part in single hotel rooms 
during the pre-Olympic competition period as well as during the Games. This was a strategy to 
minimize the risk of exposure to contagious diseases and exacerbations of asthma and allergy 
[41].  
 





In team sports, athletes may spend a significant amount of time together in close contact. It is 
reported in the 2010 Super 14 Rugby study, that it is common for all Super Rugby franchises to 
have their own training base where players are in close proximity to one another for 4-6 hours per 
day for about 4 days per week [7]. At these facilities players may share meals together and make 
use of communal shower and ablution facilities. All these factors could facilitate the spread of 
illnesses (both air-borne and by contact). It has been suggested that when athletes are members of 
sporting teams housed together, any team member who is developing a respiratory tract infection 
should be isolated as far as is practical [42]. The sharing of water bottles and water cups during 
drinks breaks in training sessions or matches also has the potential to spread infection. 
 
2.6.1.4. Increased duration of a competition or tournament 
 
Research to date on the incidence of illness in elite athletes and sports events has some 
limitations. These limitations include the reporting of an IP (percentage of athletes with illness) 
that does not allow for comparison of illness rates in competitions of different durations [12]. 
Therefore, it was suggested that the use of incidence rates (IR; illnesses per exposure, e.g., 1000 
player days) would be a more preferable methodology. 
 
In a prospective cohort study of the 2010 Super 14 Rugby Union tournament it was documented 
that the longer duration of the tournament (16 weeks) could be a possible factor resulting in the 
higher incidence of illness (20.7/1000 player days) [7] when compared to, for example, a 
prospective study of the 2 week long 2009 Confederations Cup Football tournament (16.9/1000 
player days) and the 4 week FIFA 2010 World Cup (7.7/1000 player days) [7].  
 
An illness was reported in 10.9% of athletes (IP: percentage of athletes with illness) in the 11-day 
competition period of the London 2012 Paralympic Games [12]. This was less than the 4 week 
long 2010 FIFA World Cup football (12%) [11] and remarkably lower than the 16-week Super 14 
Rugby tournament (75%) [7]. However, this comparison was limited owing to the different 
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durations of competition [12]. The more preferable methodology for comparison, illness rate (IR), 
recorded a rate of 12.8 for the Paralympic study [12] which, with this measurement, was now 
higher than the 2010 FIFA World Cup (7.7).  
For purposes of future illness studies on elite athletes, it is suggested that incidence of illness be 
reported as per 1000 athlete days in order to make comparisons with previous studies more 
appropriate. 
2.6.1.5. Environmental factors (temperature, humidity, pollution) 
It has been suggested that challenging environmental conditions, including heat and humidity, 
cold, and altitude, may pose particular risks to the health of Olympic and other high-level athletes 
[43]. The importance of environmental factors as a risk factor for illness cannot be under-
estimated. In a study conducted on the 2009 IAAF Athletics World Championships, it was 
concluded that most illnesses were caused by infection of the respiratory tract or were 
environmentally related, and that preventive interventions should focus on decreasing the risk of 
transmission, appropriate event scheduling, and heat acclimatization [16]. This was similar to the 
conclusion of the FIFA 2010 Football World Cup study, which stated that prevention of illness 
should focus on reducing the risk of infections by considering the common modes of transmission 
and environmental conditions [11]. Environmental conditions were also suggested as a possible 
factor in the recording of a higher incidence of illness during the 2010 Super Rugby study when 
compared to the 2010 FIFA World Cup football [7]. 
Environmental conditions during an international competition may be significantly different to 
those normally experienced by an athlete in his/her country of residence. For example, athletes 
residing in more temperate parts of the world may find themselves competing in cold conditions 
in Europe. They may live at sea level and then partake in a competition at altitude. Humidity may 
be a factor as well as air pollution. A number of individual factors (e.g. experience, recent health 
history status, fitness, acclimatization, physical and psychological make-up, nutritional and 




adequately adapt to, and safely tolerate, new and demanding environments [43]. In several of the 
studies that were reviewed, environmental conditions are listed as a possible cause of illness [7, 
11, 13-15].  
 
Elite athletes, particularly those engaged in endurance sports and those chronically exposed to 
airborne pollutants, irritants or allergens, are at increased risk for upper and lower airway 
dysfunction [42]. Elite athletes are repeatedly exposed to cold air during winter training and 
competitions, which may expose them to an increased risk for upper respiratory tract infections 
[19] [44]. In the 2010 Winter Olympics in Vancouver, a total of 58% of respiratory illnesses were 
suffered by Nordic skiing and skating athletes [19]. Regular changes in temperature and humidity, 
such as going from inside athlete accommodation and other living quarters to outside, has also 
been cited to contribute to the high incidence of respiratory illness [30]. In a prospective study of 
newly incurred illnesses in 1851 athletes at the Daegu 2011 Athletics World Championships, it 
was recorded that 13.5% of illnesses were attributed to environmental factors [15]. This was the 
third most common cause after infection (27.8%) and exercise-induced causes (17.5%). In this 
study, it was suggested that temperature and humidity changes between athletes' accommodation, 
outdoor, warm-up area, call room or stadium could also play a role in the high incidence of URTI. 
Gastroenteritis and dehydration were also commonly reported during elite Athletics 
Championships (around 10% and 12%–17%, respectively) [16]. Climatic conditions, nutritional 
changes and overcrowding were suggested as possible predisposing factors. 
 
Environmental factors for illness were the second most common cause recorded in a prospective 
study of newly incurred illnesses of 2592 athletes at the 2009 FINA World Championships 
(aquatics). Environmental factors was reported as a cause of 27.6% of all illnesses, second only to 
infection (49.2%) [14], and was also documented as the second most common cause of illness 
within the 32 finalist teams at the 2010 FIFA World Cup. Again, environmental factors were 
reported as the cause of 23.2% of illnesses [11].  
 
Prior to the 2008 Beijing Olympic Games, there had been extensive debates regarding air 




attempted to quantify this risk by placing devices on the balconies of athlete accommodation in 
the Olympic Village which measured ambient temperature, relative humidity and particulate 
matter with aerodynamic diameter below 10 ìm (PM10) during and shortly before the Games 
between August 3 and 24, 2008. The results showed that air quality did not result in increased 
health risks for the athletes [45]. 
 
Combustion-related pollutants such as nitrogen and sulphur oxides, the ammonium ion, organic 
aerosols, particulate matter (PM) and ozone are of concern. Inhaled PM can be causal to oxidative 
stress-related airway and vascular injury [46]. Although there is ample evidence of short-term and 
long-term exposure affecting the respiratory and the cardiovascular systems, little data are 
available demonstrating the effects of air pollution inhalation on athlete performance [47], and 
less so on infection related risks. However, it has been suggested that acute exposure to mixed 
exhaust aerosols during exercise can cause decreases in lung and vascular function in both healthy 
and asthmatic subjects[46]. Similarly, only 30 minutes of exposure to high-PM (>60 000 
particles/cm3) ambient air during exercise causes a small but significant decrease in lung function 
in non-asthmatics [48]. How this translates into infection or illness related risks to the athlete 
requires further study. 
 
2.6.2. Intrinsic risk factors for illness in athletes      
 
2.6.2.1. Female sex 
 
In athletes participating at the 2009 IAAF World Athletics Championships, a significantly higher 
incidence proportion (IP) of illness was reported in female athletes compared to their male 
counterparts (83.5 vs. 55.5 illnesses per 1000 athletes), especially for gastro-intestinal illness 
(16.7±8.5 vs. 6.5±4.8 illness per 1000 athletes)[19] [16]. Similarly, in the 2012 Summer Olympic 
Games in London, women suffered 60% more illnesses than men (86.0 vs. 53.3 per 1000 athletes) 






A study conducted at the first Winter Youth Olympic Games in Innsbruck (Austria), reported that 
11% of female and 6% of male athletes suffered from an illness, resulting in an incidence of 112.8 
illnesses per 1000 female athletes and 61.4 illnesses per 1000 male athletes, respectively [49]. In 
an observational prospective cohort study conducted on the Great Britain Olympic Team athletes 
(TeamGB) at the 2014 Sochi Winter Olympic Games, it was reported that there were more 
illnesses sustained by female athletes when compared with male athletes. In this study, 30% of 
female vs. 9% of male TeamGB athletes were affected by illness - however, this was not 
statistically significant (RR 3.33 (95% CI 1.58 to 7.01); p=0.075) [28]. Furthermore, female 
athletes who sustained illnesses during the Games were significantly older than their non-ill 
female counterparts (ill: 28.4 years, 3.7 SD; non-ill: 24.5 years, 3.6 SD; p=0.026) [28].  
 
However, a prospective cohort study of 3565 athletes competing in the London 2012 Paralympic 
Games documented that sex was not associated with an increased risk of illness [12]. This was 
consistent with the findings on gender differences in illness incidence in the 2013 FINA World 
Championships [33]. Therefore, there is some evidence that females may be at a higher risk for 
illness during sports tournaments, but this requires further investigation. 
 
2.6.2.2. Older age 
 
In athletes participating at the 2009 IAAF World Athletics Championships, the number of 
illnesses increased significantly with age (≤20 years: 45.7±29.8, 21–25 years: 58.8±16.5; 26–30 
years: 70.3±20.5; ≥30 years: 103.3±36.4 illnesses per 1000 athletes) [16]. An IP of 6.82 % was 
documented [16]. In a prospective cohort study of the 5-day 2013 European Youth Olympic 
Festival (EYOF), a lower IP of illness (2.02 %) was reported in younger athletes aged between 
13-18 years [50]. This study was the first multisport surveillance study on illnesses during the 
EYOF or any other summer Games organized for youth elite athletes. For that reason, it was 
difficult to compare the present data with similar studies. However, a prospective cohort study of 
3565 athletes competing in the London 2012 Paralympic Games, documented that older age was 





More research is required to investigate whether the lower incidence reported could be due to the 
younger age of athletes. Interestingly, most of the illnesses affected the gastrointestinal system, 
while in other studies with adults, it is the incidence of respiratory system illness which is high 
[50]. Again, further prospective studies are required to ascertain whether this is an age related 
phenomenon or an incidental finding possibly related to other illness risk factors. 
 
2.6.2.3. Body Mass Index (BMI) 
 
Body Mass Index (BMI) is a measure of overweight or obesity and is calculated from the mass 
(weight) and height of an individual. In the general population it is regarded as an important 
measure of health risk for diseases such as cardiovascular disease and diabetes. In most athletes 
who participate in sports where an increase in body mass may be an advantage, such as rugby or 
weightlifting, BMI is regarded as an inaccurate measure of body composition. This is mostly as a 
result of an increase in muscle mass which would group the athlete’s BMI in the ‘overweight’ 
category. On the opposite end of the spectrum, athletes in sports where leanness is an advantage 
such as gymnastics would have a low BMI. A more accurate measure in sports is considered to be 
body composition (BC). This can be measured in a number of ways for example, using skinfolds, 
bioelectrical impedance or dual-energy x-ray absorptiometry (DXA) scanning. 
 
In a review of the published literature, there are, to our knowledge, no studies that have explored 
the relationship between BMI (or BC) and illness in elite athletes. This could be a subject of 
future studies, especially in sports where leanness is an important performance-determining factor 
as it has been suggested that in many cases it can result in illness when training and competition is 
continued at high levels [51] [52]. 
 





It is well documented that both acute exercise bouts and regular training have various effects on 
the immune system. An acute bout of heavy exercise induces immune system responses, which 
are similar to those induced by infection [53]. A comprehensive review of the effects of both an 
acute bout of exercise and the effects of prolonged training on the immune system is beyond the 
scope of this review chapter in the dissertation. Therefore, the potential negative effects of 
exercise on the immune system, and the implication of training as a risk factor for illness, will 
only be summarized. 
 
The immune system is divided into the innate immune system, and the adaptive immune system. 
The innate immune system and the adaptive immune system each comprise both humoral and 
cell-mediated components. Several effects of exercise on both these systems and components of 
the two systems have been studied and documented. It has been suggested that the  innate immune 
system undergoes changes with an enhancement of natural killer cell activity (NKCA) and a 
suppression of neutrophil function [1]. A release of white blood cells causing a temporary 
leukocytosis after heavy training has been reported [54]. Low concentrations of lymphocytes, 
suppressed natural immunity, suppressed lymphocyte proliferation, and suppressed levels of 
secretory immunoglobulin A (sIgA) in saliva are found simultaneously with high levels of 
circulating pro-inflammatory and anti-inflammatory cytokines [55].Training at an intense level 
can result in a chronic suppression of sIgA levels (measured in saliva) [56] which provides first-
line-of-defense protection against a range of pathogens at mucosal surfaces particularly those 
lining the upper respiratory tract. This translates into an increased risk of URTI in athletes [57]. 
This period of an altered immune state following intense or prolonged exercise is referred to as 
the ‘open window’. During this ‘open window’, which may last between 3 and 72 hours, viruses 
and bacteria may proliferate increasing the risk of subclinical and clinical infection [1]. 
 
It is now generally accepted that strenuous exhausting exercise can increase susceptibility to viral 
infection during the following days or weeks [58]. Although moderate intensity exercise can 
benefit health, high intensity and prolonged exercise may have the opposite effect [59]. The 
demanding training programs of many elite athletes may suppress the immune system, and 
thereby increase susceptibility to infections [23]. Periods of intensified training lasting for one 
week or more, frequently observed over the course of a competitive season, may result in 
chronically impaired immune function and increased infection risk [60, 61].  
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A review of the literature shows that upper respiratory tract infections and skin infections are 
more prevalent in elite level athletes than in the general population, particularly during periods of 
intensive training [62]. More recently, it has been suggested that intense exercise training appears 
to result in an increase in airway inflammatory cells [63]. Therefore, ongoing research is required 
to determine whether the high incidence of URTI recorded is in fact due to infection or perhaps an 
inflammatory response as a result of other causes. It has been shown that endurance athletes from 
a variety of sports including orienteering, rowing, swimming and distance running have a 
documented increase in the incidence of URTI symptoms, possibly linked to periods of intense 
training, increased training volume, or periods of competition [62, 64]. However, increases in 
airway neutrophils, eosinophils and lymphocytes have been described under resting conditions in 
endurance sports, swimmers and cross-country skiers [63]. 
Finally it is important to note that athletes who experience recurrent infections during periods of 
maximum training or competition stress may suffer from the overtraining syndrome (OTS) [65]. 
This is a condition seen in athletes and is characterized by prolonged fatigue and under 
performance, following a period of heavy training or competition. A medical illness, such as 
infectious mononucleosis, needs to be excluded as a primary cause in order for the diagnosis of 
OTS to be made. However, an increased susceptibility to infections resulting in illness, fatigue 
and malaise may be secondary to overtraining.   
2.6.2.5. Recent close contact with an individual suffering from an illness 
Close contacts can be defined as individuals who had sustained unprotected exposure to a 
confirmed case for a significant duration of time (e.g. more than 1 h) and within a close proximity 
of 2 m [66]. The reverse would also apply, where an athlete would be exposed to an individual 
(close contact) who is suffering from an illness. It has been suggested that athletes should 
endeavor to avoid contact with persons showing signs of upper airway infections, particularly 
while undertaking intensive training schedules and before major competitions [42]. Despite close 
contact being suggested as a risk factor for illness in the general population, there are no 
published studies where this has been documented as a risk factor for illness in athletes, and 





2.6.2.6. History of allergy or asthma 
The three principal disorders which correlate allergic diseases with exercise and the practice of 
sport are exercise-induced asthma (EIA), exercise-induced anaphylaxis (EIAn) and exercise-
induced urticaria (EIU). These will not be discussed in detail in this literature review, but the 
relationship between these allergic diseases and an increased risk of illness to the athlete will be 
briefly reviewed. 
It has been suggested that there is a relationship between the risk of a viral infection and allergy, 
[67]. In a study of elite athletes (49 speed and power athletes, 71 long distance runners and 42 
swimmers), it was recorded that atopy, diagnosed using skin prick test results, was found in 48% 
(77 of 162) of the athletes studied and in 36% (16 of 45) of the control subjects (not significant). 
Furthermore, clinical pollen allergy (positive skin test reaction to pollen and symptoms of 
rhinoconjunctivitis) was significantly (p = 0.037) more common in the athletes than in control 
subjects [68]. How this translates in to infection risk has not been specifically studied. However, it 
has been suggested that allergy frequently contributes to the development and manifestation of 
respiratory problems in the athlete [69].  It has been documented that there is a marked decrease 
of salivary IgA levels in athletes during and after a training session [56]. This could be a 
predictive marker of infectious risk for athletes [70], and also for allergic patients performing 
various physical activities [67]. Studies concerning the effects of exercise on the immune system 
may also yield further data and contributions to studies on allergy and sports [67]. 
It is noted that asthma is more common in highly trained athletes than in control subjects [68]. In 
one study it was found that current asthma (current asthmatic symptoms and increased bronchial 
responsiveness) was observed in 14% (22 of 162) of the athletes and in 2% (1 of 45) of the control 
subjects (p = 0.041). Furthermore, total asthma (current asthmatic symptoms and increased 
bronchial responsiveness or physician-diagnosed asthma) was reported in 23% (37 of 162) of the 
athletes and in 4% (2 of 45) of the control subjects (p = 0.0048) [68]. 
Asthma is especially common in elite swimmers, but the risk of asthma is increased also in speed 
and power athletes as well as long-distance runners [71]. This study documented the occurrence 
(odds ratio) of current asthma as 5.49 in speed and power athletes, 2.88 in long-distance runners, 




illness (respiratory system or other) was not studied. It has however, been suggested that athletes 
with asthma should consider having an annual influenza vaccination [42]. This suggests that 
asthma could be a risk factor for respiratory illness.  
In summary, although there is some evidence that allergies are more common in athletes, there are 
little data linking a history of allergies to an increased risk of respiratory tract illness in athletes. 
This requires further study. 
 
2.7.2.7. Medication use  
 
The frequent use of medication and supplements by elite athletes across various sporting codes is 
well described in the literature. In a descriptive epidemiological study where 3 887 doping control 
forms from 12 International Association of Athletics Federations (IAAF) World Championships 
and 1 out-of-competitions season in track and field were analyzed, it was recorded that there were 
6 523 nutritional supplements used by the athletes (1.7 per athlete) and 3 237 medications were 
used by the athletes (0.8 per athlete). Non-steroidal anti-inflammatory drugs (NSAIDs; 0.27 per 
athlete, n = 884) and respiratory drugs (0.21 per athlete, n = 682) were the most common [72]. 
How these findings correlated with infection risks in the athletes was not analyzed. In a review of 
published data from 10 men’s, women’s and male adolescent FIFA World Cups [73], it was again 
found that the most frequently prescribed medication was non-steroidal anti-inflammatory drugs 
(NSAID). This is consistent with several other studies reporting on medication use amongst 
athletes.  
 
The association between medication and/or supplement use and illness in athletes, is not as well 
reported. In one study [16] one illness complaint was attributed to the use of medication. This was 
related to the digestive system. Furthermore, in 12 previous track and field Championships [72], 
19.2% of participating athletes reported to have taken NSAIDs and 3.8% antibiotics. This led the 
authors to conclude that considering the frequent use of medication reported in the literature that 
more complaints, especially of the digestive system, as well as dehydration-related effects, could 
have been expected.  
 
It is therefore an area of sports medicine that requires further research, especially considering the 




the poor understanding of related side-effects by the athletes themselves and delays in tissue 
healing [73]. 
 
2.6.2.8. Nutritional factors/supplements 
 
Scientific research has long shown that inadequate nutrition may contribute to impaired immunity 
and makes the individual more susceptible to infection [61, 74]. Recently, nutrition research has 
focused on the role of foods or specific food components in enhancing immune system 
responsiveness to challenges and thereby improving health and reducing disease risks [60]. 
Nutritional factors and the effect on illness risk are well studied in the general population. 
However, in the elite athletic population, the link between illness and specific nutritional 
deficiencies (including micronutrients) and the need for supplementation is broad, and research is 
ongoing. However, it has been suggested that inadequate or inappropriate nutrition can compound 
the negative influence of heavy exertion on immunocompetence [74]. 
 
To our knowledge, no studies have specifically examined the short-term and long-term risk of 
acute illness in groups of elite athletes using extreme dieting and DE (Disordered Eating) during 
their sports career [75]. It is likely that athletes who suffer from long-term LEA (low energy 
availability) may develop nutrient deficiencies (including anemia), chronic fatigue and increased 
risk of infections and illnesses, all of which have the potential to harm health and performance 
[75]. Energy availability is defined as the amount of ‘unused’ dietary energy remaining for all 
other metabolic processes after the energy cost of exercise training is subtracted from the daily 
energy intake [76]. Functional impairments associated with LEA include a greater prevalence of 
viral illnesses [77]. Screening for RED-S (Relative Energy Deficiency in Sport) can be undertaken 
as part of an annual periodic health examination and when an athlete presents with Disordered 
eating (De), weight loss and, amongst other symptoms, recurrent injuries and illnesses, and/or 
decreased performance /performance variability [78]. 
 
Immune function is also disturbed by substantial restrictions in intake of energy and protein as 
well as inadequate status of various micronutrients [79]. Training on a very low-fat diet (15% 
dietary fat) may be detrimental to exercise performance and leads to an overall compromised 




depleted state may result in higher levels of stress hormones and an impaired immune function 
[61]. One study examined the nutritional and activity habits of 25 adolescent amateur swimmers 
in the United Kingdom. It was concluded that if a reduced susceptibility to illness was desired, the 
swimmers should seek to ensure that their dietary intake contained an optimized proportion of 
energy derived from macronutrients. They were also to ensure that enough foods containing fibre, 
vitamin A and selenium were consumed as these were found to be deficient when compared to 
Recommended Nutrient Intake values [81].  
 
 
More recently, there has been substantial interest in the link between the immune system and 
antioxidants. Optimal antioxidant levels and immune function in athletes are not well described 
[79]. It has been suggested that a single bout of exercise causes a stress to the body's immune and 
antioxidant status. However, detecting a link between changes in nutritional status, decreases in 
concentration or activity of various immune system parameters, and the incidence of common 
illnesses such as upper respiratory tract infections is complicated. Further research is required to 
better identify this cause and effect relationship. 
 
Convincing evidence that so-called 'immune-boosting' supplements, including high doses of 
antioxidant vitamins, glutamine, zinc, probiotics and Echinacea, prevent exercise-induced 
immune impairment is lacking [74]. It is however, of interest that antioxidant supplementation has 
been proposed as complimentary therapy for athletes exposed to air pollutants. In a study 
designed to identify whether acute lung function effects of ozone can be modulated by antioxidant 
vitamin supplementation, it was found that in a group of 26 heavily exercising amateur cyclists, a 
mixture of antioxidants (Vitamin C, E and beta carotene) conferred partial protection against 
ozone-mediated adverse effects [82]. 
 
In a more recent study, it was suggested that consuming 30-60 g carbohydrate per hour during 
sustained intensive exercise attenuates rises in stress hormones such as cortisol and appears to 
limit the degree of exercise-induced immune depression [74]. It has also been shown that when 
carbohydrates (>6% CHO solution-typically sports drinks) are frequently delivered during 
prolonged exercise maintains blood glucose levels and may help to attenuate exercise induced 
changes of stress hormone levels, leukocyte cell counts and cytokine changes[61]. 
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2.6.2.9. Other factors 
Other factors may also be related to an increased risk of illness but these have to-date not been 
studied in athletes participating in tournaments. These could include a family history of allergies, 
and lifestyle factors such as smoking and alcohol use. These and other risk factors would require 
further study. 
2.7 Summary: Epidemiology and risk factors for illness in athletes 
In summary, there is clear evidence from data in a number of prospective cohort studies that 
illness is common in athletes participating in tournaments. Furthermore, data from these studies 
show that respiratory tract and gastrointestinal tract are the two most common systems affected by 
illness in athletes. Despite these findings, there are very few well-conducted studies examining the 
relationship between specific extrinsic and intrinsic risk factors for illness in athletes. In this 
review, the risk factors (extrinsic and intrinsic) associated with illness in athletes and the level of 
evidence for these risk factors were explored and these risk factors, as well as the level of 
evidence for each risk factor, are summarized in Table 2.1 
Table 2.1. A summary of extrinsic and intrinsic risk factors for illness in athletes (including 





 Risk Factor Study details and 
references 




International travel Prospective cohort study 
[10] 
I 
 Athlete accommodation Expert opinion [40] IV 
Regular close contact with 
team members 
Descriptive case series 
in Norwegian athletes 
[28} 
III 
Increased duration of 
competition or tournament 
Prospective cohort study 
[7] 
I 
Environmental factors Expert opinion [15] [14] 
[11]  





Female sex Prospective cohort 




 Older age Prospective cohort study 
[16] 
I 
Body Mass Index (BMI) No data  
High intensity and 
prolonged training  
Systematic reviews [62]  
[64] [53, 60, 61].  
II 
Recent close contact with 
and individual suffering 
from an illness 
Expert opinion [42] IV 
History of allergy or asthma Expert opinion [69] [67] IV 
Medication use Expert opinion [16] [72] IV 
Nutritional 
factors/supplements 






In summary, there are good data from one prospective cohort study indicating that international 
travel, and the duration of a tournament are extrinsic risk factors for illness in athletes. Athlete 
accommodation, close contact between athletes and environmental conditions are listed as 
extrinsic risk factors, but evidence is lacking and this requires further study. There is good data 
from a number of systematic reviews that prolonged and high intensity training, older age, and 
nutritional deficiencies are intrinsic risk factors for illness in athletes. Other intrinsic risk factors 
such as extremes of the BMI, recent close contact with infected fellow athletes, a history of 
allergic illness and medication use are listed by experts, but these require further study using 
prospective cohort study designs. The accurate documentation of these extrinsic and intrinsic risk 























Risk factors associated with illnesses during the 2010 Super Rugby tournament 




 The Super Rugby tournament is a 16-week, annual tournament held in the southern hemisphere. 
It was introduced in 1996 and was the first fully professional rugby tournament at the time 
involving 10 teams. Its popularity grew over the years and has now expanded to involve 15 teams 
from the southern hemisphere. The tournament is played over a 4-month period in the beginning 
half of the year between teams from South Africa, Australia and New Zealand. Teams play most 
weekends for the duration of the 16-week tournament. The competition is generally regarded as 
one of the most gruelling rugby competitions in the world, placing exceptional physical and 
emotional stresses on the players. Furthermore, teams have to travel across multiple time zones as 
matches are played in venues in all three countries, resulting in very demanding travel schedules 
and exposure of the athletes to different allergens and pathogenic organisms, not to mention 
climatic changes, environmental conditions and differing diets. 
The incidence of illness in in Super Rugby was relatively high when compared to several other 
illness studies during tournaments or competitions [12] [11] [13]. Reference was made to the 
possible effects of a longer duration tournament, the demanding travel schedule and to various 
other possible causes. However, the specific player-factors that may predispose a player to illness 
were not explored and have not been explored in any studies to our knowledge.  
 
Various risk factors may affect illness risk and they include the following: training history; 
medication and supplement use and lifestyle factors, such as smoking and alcohol; a family 
history of asthma or allergies; immunization history; the player’s medical history of current 
asthma, allergies, recent flu-like illness and close contact with individuals with flu-like illness. 





Therefore, the aim of this study was to determine which intrinsic risk factors may be associated 





3.2.1. Type of study 
 
This was a prospective cohort study involving 239 players from South Africa and New Zealand, 
over the 16-week duration of the 2010 Super 14 Rugby Union tournament. 
 
3.2.2. Selection of participants 
 
The UCT (University of Cape Town) Research Unit for Exercise Science and Sports Medicine 
conducted the study in conjunction with the South African Rugby Union (SARU). Research ethics 
approval was obtained from the University of Cape Town Health Sciences Research Ethics 
Committee (REC 008/2010) prior to the commencement of the tournament. 
 
All the players from South Africa and New Zealand teams participating in the 2010 Super Rugby 
tournament were approached to participate in this study. Each team consisted of a squad size that 
varied between 28 and 36 players per team. Team physicians from South Africa and New Zealand 
were contacted and support and co-operation from the team's physicians was gained. Detailed 
information about all aspects of the study was explained to players through the team physicians. 
Each team physician explained all aspects of the study including benefits and potential risks and a 
detailed player information sheet was provided to the respective players in their team. Written 
informed consent was obtained from players in order to participate. Anonymity was insured by a 
system of coding that was employed anonymously for each player and team. An independent 
party assigned the codes and these were kept in a sealed envelope in safe storage until post-
competition. 
 
All 5 teams from South Africa and 3 out of 5 teams from New Zealand took part in the study. The 





Table 3.1. Demographic data for the study population (all players, teams and player 




 No of 
players 
Age (years) Weight (kg) Height (m) Body Mass 
Index 
(kg/m2) 
All players  239 25.1 (3.2) 102.2 (11.6) 186.7 (7.2) 29.3 (2.7) 
Teams 1   28  24.9 (2.1) 105.0 (9.3) 186.1 (6.6) 30.3 (2.6) 
 2 28 26.2 (3.3) 101.0 (12.2) 186.4 (7.5) 29.0 (2.4) 
 3 34 25.5 (3.2) 100.1 (12.1) 187.4 (7.0) 28.5 (3.0) 
 4  35 24.4 (3.3) 104.3 (9.1) 187.1 (7.0) 29.8 (2.3) 
 5  14 25.8 (2.7) 105.1 (13.1) 186.1 (5.4) 30.3 (3.1) 
 6 39 25.7 (3.8) 100.2 (12.5) 186.6 (8.1) 28.6 (3.0) 
 7 31 25.4 (3.6) 104.7 (10.8) 187.5 (6.6) 29.7 (2.3) 
 8 30 23.3 (2.7) 99.0 (13.4) 185.6 (8.3) 28.7 (2.9) 
 
 
3.2.3. Pre-tournament medical data collection 
 
All the players were requested, with the assistance of the team physician, to complete a player 
medical questionnaire in the 7 days before the tournament. The purpose of this questionnaire was 
to determine any possible risk factors that may be associated with the development of illness 
during the tournament. The questionnaire data included the following: training history in the 15 
weeks prior to, and the 2 weeks prior to the commencement of the tournament, medication and 
supplement intake, lifestyle factors (including smoking and alcohol intake), a family history of 
asthma or allergies, player immunization history, history of asthma, allergies or recent flu-like 
illness and close contact with relatives/friends with flu-like illness prior to the tournament. These 
data were used to determine whether there were any risk factors associated with the development 




3.2.4. Illness data collection during the tournament 
 
Collection of data took place each day of competition, beginning 7 days before the first game the 
team played, and ending when each team played their final game. Each team physician completed 
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a daily "medical illness log" for every player. Booklets were supplied that contained daily illness 
report forms.  
A medical illness was defined as “any non-trauma related symptom or sign presenting in a player 
that required medical attention from the team physician on a specific day”. An illness was 
clinically assessed by the respective physician and was then recorded on the daily report form. 
The daily report form contained information that would be similar to that which would normally 
be utilized in the clinical care of a player and included the following: presenting signs and 
symptoms, duration of symptoms (days), final clinical diagnosis, loss of training/match days and 
the suspected etiology of the illness (a list of common causative organisms was provided).  
The physicians kept the booklets each day, and the completed booklets were only submitted to the 
research team at the conclusion of the tournament. There was 100% compliance in the return of 
all booklets. The central research office and the team physicians had regular contact during the 
tournament by either phone or email in case of any questions.  
3.2.5. Calculation of player days 
A total of 8 teams were studied during the tournament, and the daily squad sizes varied between 
28-36 players per team. As a result of some teams starting and finishing at slightly different dates
due to success in the tournament (either being knocked out prior to or in the quarter-final, semi-
final or final) and different dates of the first games, the total tournament days for each team were
therefore variable. The team physician reported the daily squad size each day. Squad sizes tended
to also be reduced during the times of international travel. Therefore, the total player days for
each team were calculated as follows: total team tournament days x daily squad size (for each
day). The total player days were 22676 for all the teams (5 South African teams=14291, 3 New
Zealand teams=8385).
3.2.6. Calculation of the incidence of illness 
Illness incidence data was calculated as number of illnesses per 1000 player days. Data were 
calculated as incidence of all illnesses, and illnesses in different systems (respiratory system and 




reported and both new and repeat illnesses were included in the incidence reports. Repeat illnesses 
were defined as 'any illness in the same player with the same final diagnostic code that was 
recorded within 7 days'. A time-loss illness was defined as 'an illness resulting in one or more lost 
training or match days'. 
 
3.2.7. Determination of risk factors associated with illness  
 
During the tournament, 141 players developed any illness. The number of players who never 
developed any illness (no illness group – Control), players who developed any illness (Any illness 
group) and players who developed illness in the respiratory system (Respiratory illness group) or 
the digestive system (Digestive illness group) in each team, is depicted in Table 3.2.  
 
Table 3.2. The number of players (and % players) in the no illness (control), any illness, 
respiratory illness, and digestive system illness groups. The number of players in each group 
by team is also included. 
 
Groups All players (n=239) 
(% of players) 
Team number 
1 2 3 4 5 6 7 8 
No illness control group 98 (41.0) 8 17 15 12 2 14 7 23 
Any illness group 141 (59.0) 20 11 19 23 12 25 24 7 
Respiratory illness group 80 (33.5) 7 11 10 7 6 18 18 3 
Digestive system illness group 60 (25.1) 10 1 11 13 5 11 5 4 
 
 
The risk factors for developing 1) any illness, 2) a respiratory illness and 3) a digestive system 
illness were studied. The following potential risk factors were studied: the training history in the 
15 weeks as well as the 2 weeks prior to the commencement of the tournament [this was divided 
into the volume of training (days/week and hours/week) as well as the type of training, rugby 
specific training, strength training, endurance and flexibility)]; medication use (asthma medication 
or anti-inflammatories), supplement use (any supplement, anti-oxidant, multi-vitamin, immune 
booster); lifestyle factors (smoking and alcohol use per week); a family history of asthma or 
allergies; the players immunization history (H1N1, varicella, hepatitis A and B, measles, 
meningitis, tetanus, yellow fever); the player medical history of asthma, allergies (any allergy, hay 
fever, sinusitis, allergic asthma) or a recent flu-like illness or close contact with someone with flu-






3.2.8. Statistical analysis of data 
 
All data from the medical questionnaire were entered into an Excel spread sheet (Microsoft 2010) 
and then analysed using the SAS Enterprise Guide (V6.1) statistical program. Factors associated 
with all illness, respiratory illness and gastrointestinal illness were first determined using a uni-
variate analysis. A multiple regression analysis was then performed to identify independent risk 
factors associated with all illness, respiratory illness and gastrointestinal illness. The statistical 




Factors associated with the development of any illness, respiratory illness and digestive illness in 
rugby players were first identified in a uni-variate analysis. 
 
3.3.1. Factors associated with any illness (Uni-variate analysis) 
 
There was no difference in the average age, height, weight or BMI of the players with any illness 
and those in the control group. 
 
3.3.1.1. Training factors 
  
 
The training history (days per week, hours per week), and type of training in the 2-week period 
prior to, and the 15-week period prior to the commencement of the tournament in the rugby 
players with no illness (control group) and players with any illness is depicted in Table 3.1. In 
addition, the % players who trained more than 4 days per week, and more than 10 hours per week 
in the 2 weeks before the tournament in the two groups is also shown in Table 3.3 
  
Table 3.3. A training history (% players) in the last 15 weeks and the last 2 weeks according 

















Training (last 15 
weeks) 
Days per week (mean (SD)] 4.8 (0.7) 4.8 (1.1) 0.692 
 Hours per week (mean (SD)] 15.6 (6.2) 16.4 (6.9) 0.378 
 Type (rugby) (% players) 34.2 (17.7) 31.3 (15.7) 0.720 
 Type (strength) (% players) 31.9 (13.8) 34.4 (14.5) 0.976 
 Type (endurance) (% players) 25.7 (11.0) 29.3 (14.2) 0.285 
 Type (flexibility) (% players) 10.5 (7.0) 9.5 (5.6) 0.330 
     
Training (last 2 weeks) Days per week (mean (SD)] 4.2 (0.8) 4.7 (1.0) 0.038 * 
 Hours per week (mean (SD)] 11.2 (5.2) 14.3 (6.7) 0.012 * 
 Type (rugby) (% players) 52.4 (18.6) 49.2 (14.9) 0.863 
 Type (strength) (% players) 24.7 (9.3) 27.8 (10.0) 0.177 
 Type (endurance) (% players) 13.9 (7.7) 16.5 (9.4) 0.477 
 Type (flexibility) (% players) 11.0 (7.6) 10.7 (6.0) 0.924 
 Training > 4 days per week (% players) 29.6 50.0 0.201 
 Training > 10 hours (% players) 34.7 60.2 0.011 * 
#: Indicates trend towards a significant difference between groups: 0.05 < p < 0.1 
*: Indicates significant differences between groups: p<0.05 
 
There was no significant difference between the two groups with regard to volume of training 
(days/week and hours/week), and type of training (rugby training, strength, endurance and 
flexibility in the 15 weeks prior to the tournament). There was also no significant difference 
between the two groups with regard to type of training (rugby training, strength, endurance and 
flexibility in the 2 weeks prior to the tournament). However, in the 2-week period prior to the 
tournament, players in the any illness group trained significantly more days per week [any illness 
group = 4.7 (1.0); control group 4.2 (0.8); p = 0.038] and more hours per week [any illness group 
= 14.3 (6.7); control group = 11.2 (5.2); p = 0.012] than players in the control group. Finally, a 
significantly greater % of players in the any illness group trained more than 10 hours per week in 
the 2 weeks prior to the tournament compared with the players in the control group (any illness 
group = 60.2%; control group = 34.7%; p = 0.011). 
 
3.3.1.2. Medication use, supplements use and lifestyle factors 
 
The use of medication, supplement usage, and lifestyle habits in the control group and the any 





Table 3.4. History of medication use (% players), supplement use (% players) and lifestyle 
habits (% players ever smoking, and weekly alcohol intake) in rugby players with no illness 
(control group) and players with any illness 
 







Medication use Current asthma medication (% players) 2.0 3.6 0.785 
 Current anti-inflammatories (% players) 1.0 7.8 0.059# 
     
Supplement use Any supplement use (% players) 85.7 85.1 0.452 
 Anti-oxidant use (% players) 27.6 14.9 0.108 
 Multivitamins use (% players) 51.0 44.0 0.375 
 Immune boosters use (% players) 21.4 12.8 0.372 
     
Lifestyle habits Smoke (ever) (% players) 11.5 6.5 0.264 
 Alcohol use per week (Beer) [mean (SD)] 3.1 (2.9) 3.1 (2.9) 0.759 
 Alcohol per week (Wine) [mean (SD)] 0.8 (1.4) 0.6 (1.2) 0.652 
 Alcohol per week (Spirits) [mean (SD)] 1.1 (2.4) 1.8 (3.8) 0.106 
#: Indicates trend towards a significant difference between groups: 0.05 < p < 0.1 
*: Indicates significant differences between groups: p<0.05 
 
 
There was no significant difference between the groups for medication use, supplement use, and 
lifestyle habits. However, there was a trend for greater % players in the any illness group to use 
anti-inflammatory medication compared with the control group (any illness group = 7.8%; control 




3.3.1.3. Family history of asthma and allergies 
A positive family history of asthma and allergies of players in the control group and those players 
in the any illness group is shown in Table 3.5.  
 
Table 3.5. Family history of asthma or allergies (% players) in rugby players with no illness 
(control group) and players with any illness 
 





Family history (% players) Asthma 22.5 17.1 0.094 # 
 Allergies 14.6 13.0 0.442 
#: Indicates trend towards a significant difference between groups: 0.05 < p < 0.1 





There was no significant difference between the groups for a family history of asthma or allergies. 
However, there was a trend for greater % players in the control group to have a positive family 
history of asthma compared with the players in the any illness group (control group = 22.5%; any 
illness group = 17.1%; p = 0.094). 
 
3.3.1.4. Immunization history 
 
The history of immunizations (% players) in the two groups is depicted in Table 3.6.  
 
Table 3.6. History of immunizations (% players) in rugby players with no illness (control 
group) and players with any illness 
 
Immunizations (% players) Control group  
(n=98) 
Any Illness group 
(n=141) 
P value 
H1N1 26.9 32.8 0.744 
Varicella 47.8 25.8    0.026 * 
Hepatitis A 37.5 46.2 0.587 
Hepatitis B 38.2 50.0 0.491 
Measles 78.1 76.1 0.651 
Meningitis 41.4 23.9    0.089 # 
Tetanus 80.7 85.8 0.594 
Yellow fever 7.0 7.0 0.645 
#: Indicates trend towards a significant difference between groups: 0.05 < p < 0.1 
*: Indicates significant differences between groups: p<0.05 
 
A significantly smaller % players in the any illness group reported immunization against varicella 
(control group = 47.8%; any illness group = 25.8%; p = 0.026). There was no significant 
difference in the two groups for other immunizations, apart from a trend that that a smaller % 
players in the any illness group reported immunization against meningitis compared with the 
control group (control group = 41.4%; any illness group = 23.9%; p=0.089).  
 
3.3.1.5. Medical history of current asthma, allergies, recent flu-like illness and close contact 
with individuals with flu-like illness 
 
The medical history of asthma, allergies or a recent flu-like illness or contact with flu-like illness 
(1 week and 6 weeks before the tournament) in the two groups is depicted in Table 3.7.  
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Table 3.7. History of current asthma, allergies, recent flu-like illness and close contact with 
individuals with flu-like illness (% players) in rugby players with no illness (control group) 






Current asthma (%) 5.2 7.2 0.821 
Allergy history (%) Allergy 21.9 24.6 0.810 
Hay fever 14.3 11.4 0.227 
Sinusitis 5.1 7.8 0.466 
Allergic asthma 5.1 2.1 0.101 
Recent flu-like symptoms (%) Last 1 week 10.3 8.6 0.439 
Last 6 weeks 11.2 14.3 0.829 
Close contact with flu-like illness (%) Last 1 week 17.0 9.4 0.049 * 
Last 6 weeks 28.4 22.9 0.127 
#: Indicates trend towards a significant difference between groups: 0.05 < p < 0.1 
*: Indicates significant differences between groups: p<0.05 
There was no significant difference between the two groups in the % players reporting current 
asthma, a history of allergies, flu-like symptoms in the period before the tournament, or close 
contact with flu-like illness in the 6 weeks before the tournament. However, a significantly larger 
% players in the control group reported close contact with flu-like illness in the week before the 
tournament, compared with players in the any illness group (control = 17.0%; any illness group = 
9.4%; p = 0.049). 
3.3.2. Factors associated with respiratory illness (Uni-variate analysis) 
There was no difference in the average age, height, weight or BMI of the players with any illness 
and those in the control group. 
3.3.2.1. Training factors 
The training history (days per week, hours per week) and type of training in the 2-week period, 
and the 15-week period, prior to the commencement of the tournament in the rugby players with 
no illness (control group) and players with respiratory illness is depicted in Table 3.8. In addition, 
the % players who trained more than 4 days per week, and more than 10 hours per week in the 2 





Table 3.8. A training history (% players) in the last 15 weeks and the last 2 weeks according 
to days and hours per week, and type of training (rugby, strength, endurance and flexibility) 
 








Training (last 15 
weeks) 
Days per week (mean (SD)] 4.8 (0.7) 5.0 (1.2) 0.748 
 Hours per week (mean (SD)] 15.6 (6.2) 15.7 (6.7) 0,885 
 Type (rugby) (% players) 34.2 (17.7) 31.8 (16.1) 0,941 
 Type (strength) (% players) 31.9 (13.8) 34.8 (15.9) 0,828 
 Type (endurance) (% players) 25.7 (11.0) 30.5 (14.1)   0,084# 
 Type (flexibility) (% players) 10.5 (7.0) 10.2 (6.3) 0,545 
     
Training (last 2 weeks) Days per week (mean (SD)] 4.2 (0.8) 4.7 (1.1)   0.025* 
 Hours per week (mean (SD)] 11.2 (5.2) 13.1 (6.6) 0.137  
 Type (rugby) (% players) 52.4 (18.6) 52.9 (15.1) 0,508 
 Type (strength) (% players) 24.7 (9.3) 27.5 (12.1) 0,295 
 Type (endurance) (% players) 13.9 (7.7) 14.9 (8.3) 0,977 
 Type (flexibility)(% players) 11.0 (7.6) 10.5 (5.7) 0,856 
 Training > 4 days per week (% players) 29.6 49.2   0.097# 
 Training > 10 hours (% players) 34.7 43.1 0.458  
#: Indicates trend towards a significant difference between groups: 0.05 < p < 0.1 
*: Indicates significant differences between groups: p<0.05 
 
There was no significant difference between the two groups with regard to volume of training 
(days/week and hours/week), and type of training (rugby training, strength, endurance and 
flexibility) in the 15 weeks prior to the tournament. There was a tendency that a greater % of 
players who took part in endurance type training in the 15 weeks prior to the tournament reported 
respiratory illness [respiratory illness group = 30.5 (14.1); control group = 25.7 (11.0); p = 
0.084)]. There was no significant difference between the two groups with regard to type of 
training (rugby training, strength, endurance and flexibility) in the 2 weeks prior to the 
tournament. However, in the 2-week period prior to the tournament, players in the respiratory 
illness group trained significantly more days per week [respiratory illness group = 4.7 (1.1); 
control group = 4.2 (0.8); p = 0.025)] than players in the control group.  
 
3.3.2.2. Medication use, supplements use and lifestyle factors 
The use of medication, supplement usage and lifestyle habits in the control group and the 





Table 3.9. History of medication use (% players), supplement use (% players) and lifestyle 
habits (% players ever smoking, and weekly alcohol intake) in rugby players with no illness 
(control group) and players with respiratory illness 
 







Medication use Current asthma medication (% players) 2.0 3.8 0.815 
 Current anti-inflammatories (% players) 1.0 8.8 0.054# 
     
Supplements use Any supplement use (% players) 85.7 85.0 0.368 
 Anti-oxidants (% players) 27.6 20.0 0.169 
 Multivitamins (% players) 51.0 53.8 0.485 
 Immune boosters (% players) 21.4 17.5 0.408 
     
Lifestyle habits Smoke (ever) (% players) 11.5 6.3 0.408 
 Alcohol use per week (Beer)  3.1 3.1 0.820 
 Alcohol per week (Wine)  0.8 0.6 0.813 
 Alcohol per week (Spirits)  1.1 1.9 0.107 
#: Indicates trend towards a significant difference between groups: 0.05 < p < 0.1 
*: Indicates significant differences between groups: p<0.05 
 
There was no significant difference between the groups for medication use, supplement use, and 
lifestyle habits. There was a trend that a greater % of players reported using anti-inflammatory 
medication developed a respiratory illness [respiratory illness group = 8.8; control group = 1.0; p 
= 0.054)] as compared to the control group.  Only 4.5% of the players used anti-inflammatory 
medication. 
 
3.3.2.3. Family history of asthma and allergies 
 
A positive family history of asthma and allergies of players in the control group and those players 
in the respiratory illness group are shown in Table 3.10. 
 
Table 3.10. Family history of asthma or allergies (% players) in rugby players with no 
illness (control group) and players with respiratory illness 
 





Family history (% players) Asthma 22.5 17.5 0.249 
 Allergies 14.6 13.8 0.889 
#: Indicates trend towards a significant difference between groups: 0.05 < p < 0.1 





There was no significant difference between the groups for a family history of asthma or allergies. 
 
3.3.2.4. Immunization history 
 
The history of immunizations (% players) in the two groups is depicted in Table 3.11. 
 
Table 3.11. History of immunizations (% players) in rugby players with no illness (control 
group) and players with respiratory illness 
 





H1N1 26.9 27.6 0.761 
Varicella 47.8 32.4 0.148 
Hepatitis A 37.5 45.5 0.255 
Hepatitis B 38.2 46.2 0.272 
Measles 78.1 80.8 0.716 
Meningitis 41.4 28.0 0.307 
Tetanus 80.7 87.3 0.206 
Yellow Fever 7.0 8.1 0.339 
#: Indicates trend towards a significant difference between groups: 0.05 < p < 0.1 
*: Indicates significant differences between groups: p<0.05  
 
There was no significant difference in the two groups for other immunizations.  
 
3.3.2.5. Medical history of current asthma, allergies, recent flu-like illness and close contact 
with individuals with flu-like illness 
 
The medical history of asthma, allergies or a recent flu-like illness or contact with flu-like illness 
(1 week and 6 weeks before the tournament) in the two groups is shown in Table 3.12. 
 
Table 3.12. History of current asthma, allergies, recent flu-like illness and close contact with 
individuals with flu-like illness (% players) in rugby players with no illness (control group) 





















Current asthma (%)  5.2 7.5 0.845 
     
Allergy history (%) Allergy 21.9 27.5 0.661 
 Hay fever 14.3 13.8 0.432 
 Sinusitis 5.1 10.0 0.422 
 Allergic asthma  5.1 3.8 0.270 
     
Recent flu-like symptoms (%) Last 1 week 10.3 13.8 0.858 
 Last 6 weeks 11.2 17.5 0.331 
     
Close contact with Flu-like illness (%) Last 1 week 17.0 7.7    0.038 * 
 Last 6 weeks 28.4 22.5 0.231 
#: Indicates trend towards a significant difference between groups: 0.05 < p < 0.1 
*: Indicates significant differences between groups: p<0.05 
 
There was no significant difference between the two groups in the % players reporting current 
asthma, a history of allergies, flu-like symptoms in the period before the tournament, or close 
contact with flu-like illness in the 6 weeks before the tournament. However, there was a 
significantly larger % players in the control group reporting close contact with individuals 
suffering from flu-like illness in the week before the tournament, compared with players in the 
respiratory illness group (control = 17.0%; respiratory illness group = 7.7%; p = 0.038). 
 
3.3.3. Factors associated with digestive illness (Uni-variate analysis) 
On average, the players with digestive illness were 1 year older and also 5 kg heavier than the 
players without a digestive illness. 
 
3.3.3.1. Training factors 
 
The training history (days per week, hours per week) and type of training in the 2-week period 
prior to, and the 15 weeks prior to the commencement of the tournament in the rugby players with 
no illness (control group) and players with digestive system illness is depicted in Table 3.13. In 
addition, the % players who trained more than 4 days per week, and more than 10 hours per week 





Table 3.13. A training history (% players) in the last 15 weeks and the last 2 weeks 
according to days and hours per week, and type of training (rugby, strength, endurance and 
flexibility) 
 







Training (last 15 weeks) Days per week (mean (SD)] 4.8 (0.7) 4.7 (1.2) 0.309 
 Hours per week (mean (SD)] 15.6 (6.2) 14.7 (6.4) 0.727 
 Type (rugby) (% players) 34.2 (17.7) 30.1 (15.0) 0.993 
 Type (strength) (% players) 31.9 (13.8) 31.6 (12.9) 0.621 
 Type (endurance) (% 
players) 
25.7 (11.0) 29.9 (12.8) 0.566 
 Type (flexibility) (% 
players) 
10.5 (7.0) 10.0 (6.2) 0.702 
     
Training (last 2 weeks) Days per week (mean (SD)] 4.2 (0.8) 4.8 (1.3)   0.041 * 
 Hours per week (mean (SD)] 11.2 (5.2) 14.4 (6.0)   0.025 * 
 Type (rugby) (% players) 52.4 (18.6) 44.9 (14.2) 0.238 
 Type (strength) (% players) 24.7 (9.3) 27.6 (8.9) 0.213 
 Type (endurance) (% 
players) 
13.9 (7.7) 17.1 (9.3) 0.446 
 Type (flexibility) (% 
players) 
11.0 (7.6) 11.7 (6.4) 0.670 
 Training > 4 days per week 
(% players)  
29.6 54.4  0.083 # 
 Training > 10 hours in 2 
weeks (% players) 
34.7 68.9 0.004 * 
#: Indicates trend towards a significant difference between groups: 0.05 < p < 0.1 
*: Indicates significant differences between groups: p<0.05 
 
There was no significant difference between the two groups with regard to volume of training 
(days/week and hours/week), and type of training (rugby training, strength, endurance and 
flexibility) in the 15 weeks prior to the tournament. There was also no significant difference 
between the two groups with regard to type of training (rugby training, strength, endurance and 
flexibility) in the 2 weeks prior to the tournament. However, in the 2-week period prior to the 
tournament, players in the digestive system illness group trained significantly more days per week 
[digestive system illness group = 4.8 (3.1); control group 4.2 (0.8); p = 0.041)] and more hours 
per week [digestive system illness group = 14.4 (6.0); control group = 11.2 (5.2); p = 0.025)] than 
players in the control group. In addition, a significantly greater % of players in the digestive 
system illness group trained more than 10 hours per week in the 2 weeks prior to the tournament 
compared with the players in the control group (digestive system illness group = 68.9%; control 
group = 34.7%; p = 0.004). There was also a trend towards a greater % of players in the digestive 
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system illness group who reported training more than 4 days per week in the 2 weeks before the 
tournament (digestive system illness group = 54.4%; control group = 29.6%; p = 0.083). 
3.3.3.2. Medication use, supplements use and lifestyle factors 
The use of medication, supplement usage and lifestyle habits in the control group and the 
digestive system illness group are shown in Table 3.14. 
Table 3.14. History of medication use (% players), supplement use (% players) and lifestyle 
habits (% players ever smoking, and weekly alcohol intake) in rugby players with no illness 









Medication use Current asthma medication (% players) 2.0 3.3 0.830 
Current anti-inflammatories (% players) 1.0 8.3 0.028 * 
Supplements use Any supplement use (% players) 85.7 76.7   0.096 # 
Anti-oxidants (% players) 27.6 10.0 0.114 
Multivitamins (% players) 51.0 33.3 0.189 
Immune boosters (% players) 21.4 5.0    0.065 # 
Lifestyle habits Smoke (ever) (% players) 11.5 3.5 0.125 
Alcohol use per week (Beer) 3.1 2.9 0.784 
Alcohol per week (Wine) 0.8 0.6 0.720 
Alcohol per week (Spirits) 1.1 1.4 0.524 
#: Indicates trend towards a significant difference between groups: 0.05 < p < 0.1 
*: Indicates significant differences between groups: p<0.05 
There was no significant difference between the groups for supplement use, and lifestyle habits. 
There was a significantly greater % of players in the digestive system illness group who reported 
use of anti-inflammatory medication (digestive system illness group = 8.3%; control = 1.0%; p = 
0.028) compared with players in the control group. In addition, there was a trend that a smaller % 
players in the digestive system illness group reported using any supplement (digestive system 
illness group = 76.7%; control = 85.7%; p = 0.096). There was also a trend that a smaller % of 
players in the digestive system illness group reported using immune boosters (digestive system 
illness group = 5%; control = 21.4%; p = 0.065) compared to the control group. 





A positive family history of asthma and allergies of players in the control group and those players 
in the digestive system illness group are shown in Table 3.15. 
 
Table 3.15. Family history of asthma or allergies (% players) in rugby players with no 
illness (control group) and players with digestive system illness 
 
 Control group (n=98) Digestive system illness 
(n=60) 
P value 
Asthma 22.5 17.0 0.225 
Allergies 14.6 5.2    0.039 * 
#: Indicates trend towards a significant difference between groups: 0.05 < p < 0.1 
*: Indicates significant differences between groups: p<0.05 
 
There was no significant difference between the groups for a family history of asthma. However 
there was a significantly smaller % of players in the digestive system illness group that reported a 
positive family history of allergies (digestive system illness group = 5.2%; control = 14.6%; p = 
0.039) compared to the control group. 
 
3.3.3.4. Immunization history 
 
The history of immunizations (% players) in the two groups is depicted in Table 3.16. 
 
Table 3.16. History of immunizations (% players) in rugby players with no illness (control 
group) and players with digestive system illness 
 
 Control group  
(n=98) 
Digestive system illness 
(n=60) 
P value 
H1N1 26.9 29.8 0.421 
Varicella 47.8 11.3 0.001 * 
Hepatitis A 37.5 42.6 0.341 
Hepatitis B 38.2 49.1 0.517 
Measles 78.1 77.2 0.703 
Meningitis 41.4 16.7 0.020* 
Tetanus 80.7 82.1 0.371 
Yellow Fever 7.0 0.0 NA 
#: Indicates trend towards a significant difference between groups: 0.05 < p < 0.1 
*: Indicates significant differences between groups: p<0.05 
NA: Not analyzed (too small sample size) 
 
A significantly smaller % of players in the digestive system illness group reported immunization 




group = 11.3%; p = 0.001). There was also a significantly smaller % of players in the digestive 
system illness group who reported immunization against meningitis (control group = 41.4%; 
digestive system illness group = 16.7%; p = 0.020).  
 
3.3.3.5. Medical history of current asthma, allergies, recent flu-like illness and close contact 
with individuals with flu-like illness 
 
The medical history of asthma, allergies or a recent flu-like illness or contact with flu-like illness 
(1 week and 6 weeks before the tournament) in the two groups is shown in Table 3.17. 
 
Table 3.17. History of current asthma, allergies, recent flu-like illness and close contact with 
individuals with flu-like illness (% players) in rugby players with no illness (control group) 
and players with digestive system illness 
 






Current asthma (%)  5.2 10.2 0.282 
     
Allergy history (%) Allergy 21.9 19.0 0.653 
 Hay fever 14.3 13.3 0.634 
 Sinusitis 5.1 8.3 0.448 
 Allergic asthma  5.1 0.0  
     
Recent flu-like symptoms (%) Last 1 week 10.3 3.4 0.116 
 Last 6 weeks 11.2 10.2 0.767 
     
Close contact with Flu-like illness (%) Last 1 week 17.0 5.2    0.063 # 
 Last 6 weeks 28.4 20.3 0.149 
#: Indicates trend towards a significant difference between groups: 0.05 < p < 0.1 
*: Indicates significant differences between groups: p<0.05 
 
 
There was no significant difference between the two groups in the % players reporting current 
asthma, a history of allergies, flu-like symptoms in the period before the tournament, or close 
contact with flu-like illness in the 6 weeks before the tournament. However, there was a trend 
towards a smaller % of players in the digestive system illness group who reported a close contact 
with a flu-like illness in the week before the tournament (control group = 17.0%; digestive system 






3.3.4. Independent risk factors associated with any illness, respiratory illness and digestive 
illness (Multiple regression analysis) 
 
Independent risk factors associated with any illness, respiratory system illness and digestive 
system illness in rugby players are depicted in Table 3.18. 
 
Table 3.18. Independent risk factors associated with any illness, respiratory system illness 
and digestive system illness in rugby players (multiple regression analysis) 
 
Group Risk factor Estimate SE F p value OR 95% CI 
Any illness Training days in the 2 weeks before 
the tournament 0.543 
0.2









Training days in the 2 weeks before 
the tournament 0.593 
0.2





% endurance training time in the 15 
weeks before the tournament 0.04 
0.0





Use of anti-inflammatory drugs 2.47 1.14 4.59 0.034 
11.





Training days in the 2 weeks before 
the tournament 0.8 
0.3
2 6.35 0.013 2.2 1.2 – 4.2 
Varicella vaccination 2.11 0.59 
12.8





An increased number of training days in the 2 weeks before the tournament was an independent 
risk factor for any illness (OR = 1.72; 95% CI, 1.03 to 2.88; p=0.038), respiratory system illness 
(OR = 1.81; 95% CI, 1.10 to 2.98; p = 0.021), and digestive system illness (OR = 2.2; 95% CI, 1.2 
to 4.2; p = 0.013). In all 3 cases the odds of illness increase with about 2 points for every 1 
additional day of training. 
 
The % time spent on endurance training in the 15 weeks before the tournament (OR = 1.04; 95% 
CI, 1.01 to 1.08; p = 0.02), and the use of anti-inflammatory drugs (OR = 11.7; 95% CI, 1.2 to 
114; p = 0.034) were additional independent risk factors associated with respiratory system 
illness. The odds for developing a respiratory illness was 11 times higher for players taking anti-
inflammatory medications compared to those who did not. 
No vaccination against varicella was an additional independent risk factor associated with 










In this prospective cohort study, intrinsic risk factors for the development of illness (any illness, 
respiratory system illness, and digestive system illness) in elite rugby players participating in a 
16-week tournament were explored. Specifically, the following intrinsic risk factors were studied: 
training history prior to the commencement of the tournament, current medication and supplement 
use, lifestyle factors, a family history of asthma or allergies, player immunization history, player 
medical history of asthma and allergies, and exposure to flu-like illness or close contact with 
someone with flu-like illness before the tournament. 
 
The main findings of this study are that: 1) an increased number of training days in the 2 weeks 
before the tournament was an independent risk factor for any illness, respiratory system illness, 
and digestive system illness, 2) the % time spent on endurance training in the 15 weeks before the 
tournament, and the use of anti-inflammatory drugs were additional independent risk factors 
associated with respiratory system illness, 3) no vaccination against varicella was an additional 
independent risk factor associated with digestive system illness, and 4) medication and 
supplement use, lifestyle factors, a family history of asthma or allergies, player medical history of 
asthma and allergies, and exposure to flu-like illness or close contact with someone with flu-like 
illness before the tournament were not associated with increased risk of illness. 
 
This study is, to our knowledge, the first prospective cohort study to determine potential intrinsic 
risk factors for illness in rugby players during a tournament, in this particular case the 2010 Super 
Rugby tournament. Consequently, it is difficult to make comparisons with previous studies. It has 
previously been shown that there is a high incidence of illness (20.7/1000 player days) during the 
same tournament [7], and that the predominant illnesses were of the respiratory and digestive 
systems [7]. Similar patterns of illness in the different systems have also been documented in 
several other studies across different sporting codes, including the 2009 FIFA Confederations Cup 
[13], FIFA 2010 World Cup football [11], 2012 Summer Olympic Games [17], 2010 Winter 




been no studies examining intrinsic player factors that may be related to the incidence of illness in 
rugby players. To our knowledge, the only other study to date to examine risk factors for illness in 
other elite athletes was conducted in outdoor athletics on 1342 registered athletes during the 2012 
Helsinki European Athletics Championships [83]. In this study, it was concluded that illness risk 
factors remain unclear. 
 
The first main finding in our study was that an increased number of training days in the 2 weeks 
before the tournament was an independent risk factor for any illness, respiratory system illness, 
and digestive system illness. This indicates two potential factors for consideration 1) that higher 
training volumes in a short period (2 weeks) could place players at a higher risk of developing an 
illness and 2) that there is an increased incidence of illness close to the start of a competition. Our 
finding is consistent with observations reported in other sports. 
 
There is some evidence in studies, to suggest that there is a relationship between increased 
training volumes (hours/day or days/week) and increased risk of illness in elite athletes. In a study 
conducted at the Australian Institute of Sport, 32 elite male and female triathletes and cyclists, 31 
male and female recreationally competitive triathletes and cyclists, and 20 male and female 
untrained sedentary controls were recruited for a 5-month prospective surveillance study. The 
results showed that the highest cluster of illness episodes occurred during the highest training 
periods of December and January. It also reported that elite athletes accounted for 57% of all 
cases [30]. In a study investigating the incidence of URTI during the Two Oceans Ultra-Marathon 
(56km) in South Africa, it was documented that runners who completed the highest training 
weekly distance (kilometers/week) in preparation for the race experienced the highest incidence 
of symptoms of URT symptoms [84]. In a prospective cohort study of 35 elite yachtsmen during 
the 2003 America’s Cup race, periods of high training volume were a major risk factor for the 
development of illness [27]. However, in this study no further information was given regarding 
the exact volumes of training studied. 
 
Upper respiratory tract infections (URTI) are commonly experienced by elite endurance athletes, 
particularly around the time of competition [30]. There is evidence that illnesses cluster around 
the time of competition possibly as a consequence of training-induced immunosuppression, 
increased anxiety and psychosocial stress, and increased exposure to pathogens [57] [65]. In a 
review of studies of immunity in elite athletes and associations with intensity, volume and 
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duration of exercise, it was concluded that following relatively short periods (1–3 weeks) of 
intensified training (longer duration and higher volume), marked reductions in neutrophil 
function, lymphocyte proliferation, sIgA, and the circulating number of T cells producing IFN-γ 
(interferon gamma) were observed [85]. It was suggested that these immune changes are 
associated with an increased risk of respiratory illness in the athletes. 
Similarly, Nieman proposed a J-shaped Model which shows the relationship between exercise 
workload and URTI risk [86]. This model suggests that the risk of URTI symptoms may decrease 
below that of a sedentary individual when one engages in moderate exercise training. But the risk 
of URTI symptoms may rise above average during periods of excessive amounts of high-intensity 
exercise.  
Again, in our study we found that an increased volume of training (days/week) in the period 2 
weeks before the 2010 Super 14 Rugby tournament was associated with a significantly higher risk 
of illness. This is consistent with the aforementioned studies, which show that increased training 
volumes and intensities result in a suppression of the immune system that places athletes at a 
higher risk of illness. 
Apart from increased days of training, we also found that the % time spent on endurance training 
in the 15 weeks before the tournament (OR = 1.04; 95% CI, 1.01 to 1.08; p = 0.02) was an 
additional independent risk factor associated with respiratory system illness. It has been 
documented that some endurance athletes undergoing strenuous training have an increased 
susceptibility to URTI as a result of exercise-induced immunosuppression [57]. Components of 
the immune system respond differently to the chronic stress of intense, endurance-type exercise 
[1]. While the adaptive immune system remains largely unchanged, the innate immune system 
undergoes changes with an enhancement of natural killer cell activity and a suppression of 
neutrophil function. In the literature this period of an altered immune state is referred to as the 
‘open window’. During this ‘open window’, which may last between 3 and 72 hours, viruses and 
bacteria may proliferate increasing the risk of subclinical and clinical infection [1].  
It has been suggested by investigators that athletes showing the most extreme post-exercise 
immunosuppression are also those athletes that contract an infection during the ensuing 1 to 2 
weeks [1]. This was studied in a group of 150 randomly selected Ultra-Marathon runners in the 
Two Oceans marathon in Cape Town where symptoms of URTI occurred in 33.3% of runners 





Several studies have demonstrated that the concentration and flow rate of secretory 
immunoglobulin A (sIgA), the major effector of host resistance to URTI, decreases after intense 
endurance exercise [85] [57]. It has been documented that there is a correlation between a 
decrease in SIgA (particularly salivary IgA1) during training [56], and an increase in the number 
of respiratory infections in elite athletes.  Future studies may begin to focus on other factors, 
including genetic factors, which may predispose athletes to illness. Cox et al have already 
examined cytokine gene polymorphisms and have found a possible link with upper respiratory 
symptoms (URS) in highly trained athletes [87].  
 
In our study, the use of anti-inflammatory drugs was an independent risk factor associated with 
respiratory system illness (OR = 11.7; 95% CI, 1.2 to 114; p = 0.034). From our data, it is not 
clear what the relationship between the use of anti-inflammatory drugs and respiratory illness is. 
Furthermore, the data also needs to be interpreted with caution because overall only very few 
players reported use of anti-inflammatory medication (<5%). The reasons why players made use 
of anti-inflammatory medication were also not studied. One possible explanation is that players 
who have a propensity towards respiratory system illness took anti-inflammatory medication as a 
precaution or preventative measure, and this has been previously reported as a measure to reduce 
the effect of ongoing airway inflammation [88]. In future studies, the relationship between anti-
inflammatory medication use and risk of respiratory illness needs to be explored. 
 
In our study we showed that there was a relationship between no reported vaccination against 
varicella, and increased risk factor of digestive system illness (OR = 8.3; 95% CI, 2.6 to 26.7; p = 
0.0005). However, we also noted a large variation in reported varicella immunizations among 
players and not all players completed this question. Hence, this finding needs to be interpreted 
with caution. There are no known data that link the administration of the varicella vaccine to the 
development of digestive system illness, and this could possibly be explored further in future 
studies.  
 
In our study we also report several factors that were not associated with an increased risk of 
illness. The use of asthma medication was not found to be an independent risk factor. Similarly, 
player medical history of asthma or allergies, as well as a family history of asthma or allergies, 




supplements, anti-oxidants, multivitamins or immune boosters were not at a significantly reduced 
risk for illness than those who never used them. Interestingly, players who smoked or consumed 
alcohol were not at any significant risk of illness compared to those who never smoked or use 
alcohol. Lastly, we found that players who had had close contact with someone who was suffering 
from a flu-like illness did not significantly affect the player’s risk of developing an illness. Future 
studies could record close contact with someone with gastroenteritis and the associated risk of 
developing digestive system illness. 
 
Given all these observations, there is substantial clinical interest in understanding the relationships 
between exercise, training, immune function and the practical intervention strategies to maintain 
immuno-competence in athletes undertaking intensive training programs [89] prior to and 
especially during competition time. Sports performance may be reduced during times of illness 
and this remains a concern for coaches, athletes and medical staff alike [90]. For example, during 
the Winter Olympic Games 2010 [19], it was reported that a reduced illness rate in the Norwegian 
team was associated with a higher team performance.  
The identification of risk factors for illness will allow medical staff to develop and implement 
preventative measures for illness, specifically respiratory and digestive system illness. An 
example of the practical implementation of preventative measures to improve performance was 
reported in the Norwegian Winter Olympics team [41]. In this study, it was concluded that 
athletes with a heavy competition load and resultant increased susceptibility to respiratory tract 
infections and airway problems were accommodated for the most part in single rooms. Various 
other strategies were also strongly advised, and included the use of disinfectant hand gels, 
minimizing of hand-shaking, and the use of special indoor air cleaning systems [41].  
 
Another study suggested the monitoring of mucosal immune parameters (such as salivary IgM 
and IgA) during critical training periods and establishing personal profiles for individual athletes 
which may provide an assessment of the risk status of an athlete for URTI [85].Prophylactic 
antibiotics (ciprofloxacin) were used by the medical team to lower the incidence of Travellers’ 
Diarrhoea (TD) in Team England athletes to the Youth Commonwealth Games in India in 2008 
[34]. Another study suggested the monitoring of mucosal immune parameters (such as salivary 
IgM and IgA) during critical training periods and establishing personal profiles for individual 




The practical clinical application from our study findings is a recommendation to include the 
tapering of training loads in the 2 weeks before the commencement of the tournament as well as 
to consider reductions in the endurance-training element in the pre-season period (approximately 
15 weeks before the tournament). It has also previously been suggested that following illness, a 
hierarchical return to full training be implemented, where the frequency of sessions is increased 
first, followed by a systematic increase in training volume or duration, and finishing with 
increases in intensity of training [91].  We also noted the possible relationship between illness and 
anti-inflammatory medication and therefore team physicians should discourage the excessive use 
of anti-inflammatories. 
 
3.5. Strengths and limitations of the study 
 
The strengths of the present study are that it is, to our knowledge, the first prospective cohort 
study to determine intrinsic player factors associated with illness in elite rugby players. This study 
represents a large prospective cohort study in rugby union, and was conducted in a tournament of 
a long duration played at a very high level. Furthermore, team physicians recorded daily illness 
data with a very high compliance rate, and the incidence rate of illness was accurately 
documented.  
 
However, the team physician used clinical criteria in concluding their diagnosis as laboratory 
studies or other special investigations were not consistently available. There was also a reliance 
on players to accurately recall and enter their medical history, including immunizations and 
family history of asthma and allergies. In addition, training loads were not documented during the 
tournament - only before the tournament. Finally, these data may not be generalizable to other 
sporting codes as the study was conducted in Rugby Union players during a tournament.  
 
3.6. Summary and clinical implications 
 
In summary, the main findings and clinical implications of the data presented in this study are: 
 
 An increased number of training days in the 2 weeks before the tournament was an 





  Higher training volumes in a short period (2 weeks) could place players at a higher risk of 
developing an illness. 
 There is an increased incidence of illness close to the start of a competition. 
 The % time spent on endurance training in the 15 weeks before the tournament was an 
additional independent risk factor associated with respiratory system illness. 
 A recommendation to include the tapering of training loads in the 2 weeks before the 
commencement of the tournament as well as to consider reductions in the endurance-
training element in the pre-season period (approximately 15 weeks before the tournament). 
 The use of anti-inflammatory medication was an independent risk factor associated with 
respiratory system illness. 
 Team physicians should discourage the excessive use of anti-inflammatories. 
 The use of asthma medication was not found to be an independent risk factor.  
 Player medical history of asthma or allergies, as well as a family history of asthma or 
allergies, was also not found to be a risk factor for the development of illness.  
 Players that made use of supplements, anti-oxidants, multivitamins or immune boosters 
were not at a significantly reduced risk for illness than those who never used them.  
 Players who smoked or consumed alcohol were not at any significant risk of illness 
compared to those who never.  
 Players who had had close contact with someone who was suffering from a flu-like illness 
did not significantly affect the player’s risk of developing an illness. 
 The identification of risk factors for illness will allow medical staff to develop and 
















Summary and conclusion 
 
In a number of epidemiological studies in athletes during times of training, competition or 
tournaments, data show that illness is an important component of athlete health and performance. 
Data show that illness significantly contributes to the health care of the athlete during 
tournaments, and that the highest incidence of illness is recorded in the respiratory system 
followed by the digestive system. However, to date, there are very few studies that have 
determined independent risk factors for illness in athletes in the tournament setting. These data are 
essential to plan prevention strategies to protect the health of the athlete. 
The focus of this dissertation was to investigate risk factors for illness in athletes, with specific 
reference to the sport of Rugby Union during a 16-week international tournament. In Chapter 2, a 
comprehensive review, using evidence-based criteria, was undertaken to determine risk factors for 
illness in athletes in general, and specifically in rugby players. The main findings of this review 
were as follows:  
 Respiratory system and digestive system illness consistently rank as the most common 
systems affected 
 Extrinsic risk factors associated with an increased risk of illness were: international travel, 
close quarter living, increased competition/tournament duration, environmental factors 
(heat, humidity, pollution) and nutritional factors 
 Intrinsic risk factors were: female sex, older age group and training associated factors 
 There was little or no evidence to suggest an association with BMI, recent close contact 
with someone suffering from flu, history of allergy or asthma and medication use 
 
An original research study was therefore undertaken to determine the independent intrinsic risk 
factors for illness in rugby players during a prolonged 16-week tournament, and this was 
presented in Chapter 3. 
The strengths of this study are that it is, to our knowledge, the first prospective cohort study to 
determine intrinsic player factors associated with illness in elite rugby players. This study 
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represents a large prospective cohort study in Rugby Union, and was conducted in a tournament 
of a long duration played at a very high level.  
The results of this study contributed to the body of knowledge on the risk factors for illness as 
follows: 
 An increased number of training days in the 2 weeks before the tournament was an
independent risk factor for any illness, respiratory system illness, and digestive system
illness.
 The % time spent on endurance training in the 15 weeks before the tournament was an
additional independent risk factor associated with respiratory system illness.
 Use of anti-inflammatory medication was an independent risk factor associated with
respiratory system illness.
There is substantial clinical interest in understanding the relationships between exercise, training, 
immune function and the practical intervention strategies to maintain immuno-competence in 
athletes undertaking intensive training programs prior to and especially during competition time.  
The identification of risk factors for illness will assist team physicians to develop and implement 
preventative measures for illness, specifically respiratory and digestive system illness.  
These prevention strategies can be adjusted at various points during the season to adapt to certain 
high risk periods. Coaches and trainers can now also anticipate how the effects of illnesses are 
likely to alter squad composition during and prior to the 4-month tournament and plan training 
sessions accordingly. 
The findings from this research study therefore add to the body of knowledge on the risk factors 
associated with illness. The risk factors for illness presented in Chapter 2 can now be modified 
and summarized as follows (Table 4.1.) 
Table 4.1. A summary of extrinsic and intrinsic risk factors for illness in athletes (including 




 Risk Factor Study details and 
references 




International travel Prospective cohort study 
[10] 
I 
 Athlete accommodation Expert opinion [40] IV 
Regular close contact 
with team members 
Descriptive case series 
in Norwegian athletes 
[28} 
III 
Increased duration of 
competition or 
tournament 
Prospective cohort study 
[7] 
I 
Environmental factors Expert opinion [15] [14] 
[11]  








Female sex Prospective cohort 




 Older age Prospective cohort study 
[16] 
I 
Body Mass Index (BMI) No data  
High intensity and 
prolonged training  
Systematic reviews [62]  
[64] [53, 60, 61].  
II 
Increased number of 
training days 2 weeks 
before 
tournament/competition 




type training 15 weeks 
before tournament or 
competition 
Prospective cohort study 
(dissertation) 
I 
Recent close contact 
with and individual 
suffering from an illness 
Positive association: 
Expert opinion [42] 
No association: 







History of allergy or 
asthma 
Positive association: 





Prospective cohort study 
(dissertation) 
I 
Family history of 
allergy or asthma 
No association: 








Expert opinion [16] [72] 
Prospective cohort study 
(dissertation) 
No association: 



















Prospective cohort study 
(dissertation) 
I 
In addition, this study also highlighted the importance of recording true incidence of illness. It is 
therefore also suggested that the most accurate measure is illnesses per 1000 athlete days as 
opposed to illnesses per 1000 athletes. This will allow for more accurate comparisons to be made 
in illness studies in athletes across different sporting codes and durations of competition. 
Practical clinical recommendations for athletes to reduce the risk of illness 
Based on the review of the risk factors for elite athletes, and the findings from the original 
research study in this dissertation, the following practical clinical recommendations can be given 
to team physicians and athletes to reduce the risk of illness during training and tournaments or 





Table 4.2.: Practical clinical recommendations to reduce the risk of illness in athletes, based 
on current known and postulated risk factors for illness. 
 
Risk factor Practical clinical recommendation 
 
Extrinsic risk factors 
 








 Regular close contact with team 
members 
 









Intrinsic risk factors 
 


















 Endurance- type/prolonged 
 
 
 Increased attention to enhancement 
of athlete immunity particularly 
when departing home country 
 
 Isolate ill players or players with 
higher susceptibility to respiratory 
illness from rest of team 
 
 Employ specific hygiene 
interventions 
 
 Increased awareness of higher 




 Recommended reduction in high 
intensity exercise in hot, humid 




 Non-modifiable risk factor; 
increased awareness of possible 
higher incidence of illness 
 
 Non-modifiable risk factor; 
increased awareness of possible  




 Nil specific as yet 
 
 Limit high intensity exercise 2 
weeks prior to 
tournament/competition; adequate 




 Increased risk for respiratory 
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training 
 Recent close contact with an
individual suffering from an illness
 History of allergy or asthma
 Recent flu-like illness
 Medication use




system illness; adequate recovery 
post endurance exercise 
 Avoidance of someone who is ill is
advised
 No specific increased risk of
illness but beware of performance
related effects
 No increased risk; ensure adequate
recovery before engaging in high
intensity exercise
 Athletes with higher susceptibility
to respiratory illness to avoid
excessive anti-inflammatory usage
 No associated increased risk  but
be aware of other adverse health
effects
 Nutritional deficiencies associated
with increased risk of illness; be
aware of importance of
maintaining a healthy nutritional
status
 No increased risk but be aware of
importance of immunizations to
prevent other illnesses
75 
Recommendations for further research to reduce the risk of illness 
Finally, as a result of this study, we suggest the following areas for further research. 
 Continued research into the incidence of illness in elite rugby players, as this particular
topic has only two research studies that we are aware of
 Further study is required to uncover the causes of unidentified but symptomatic URI in
athletes
 A clear need for better understanding of the aetiology and risk factors of URTI in elite
athletes
 It is suggested that future studies on the incidence of illness be reported as illnesses per
1000 athlete days in order to make comparisons with previous studies more appropriate.
 Further research into the effects of travel on the incidence of illness in athletes
 Continued studies into the relationship between allergies and illness
 Further studies into gender- and age-related higher incidences of illness
 Detecting a link between changes in nutritional status, decreases in concentration or
activity of various immune system parameters, and the incidence of common illnesses
such as upper respiratory tract infections requires further research to better identify this
cause and effect relationship
 BMI, whether increased or decreased, and its association with illness needs to be studied
further
 Considering the widespread use of medication in sports, the effects on athlete general
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Appendix A: Participant Information Sheet  
 
Team:   _____________ 
Player no: _____________ 
 
 
PLAYER MEDICAL QUESTIONNAIRE 
 
2010 SUPER 14  
 
ILLNESS RESEARCH STUDY 
 
This questionnaire has been constructed by the Medical Research team.  The information 
obtained from these questionnaires is essential for the planning of medical care during 
events such as future Super 14 competitions. We acknowledge that completion of the 
questionnaires may take some time and we appreciate your valuable time to complete this 
questionnaire in the 7 day period just before the start of 2010 Super 14 Rugby tournament. 
The completion of the questionnaires is voluntary; all the information will be kept 
confidential and will only be used for research and medical care planning purposes.  
 
Prof Martin Schwellnus  
 
Player information and instructions 
 
Please read the study information and then sign the Informed Consent section on the third page 
if you agree to participate in this research study.  
 
Please complete the questionnaire with the help of your team doctor in the 7 day period before 
the start of the 2010 Super 14 Rugby tournament.  
 
Please answer each question in Sections A to E of the questionnaire by filling in the details in the 








Please hand the forms to your team doctor, who will be asked to submit the completed forms to 
the University of Cape Town Research Office.  
 
STUDY INFORMATION AND INFORMED CONSENT 
Section A Basic Details 
Section B Training History 
Section C History of Medication and Supplement Use as well as Lifestyle and Habits History 
Section D Family Medical History 
Section E General Personal Medical History 




STUDY INFORMATION AND INFORMED CONSENT 
A research study will be conducted to determine how common medical conditions and illness are in 
players who participate in the 2010 Super 14 Rugby tournament in February to May 2010. This tournament 
will be held at venues in South Africa, New Zealand and Australia. The detailed information on each of the 
components of the study is as follows:  
The purpose of this study is to determine how common a variety of medical conditions and illness 
are in rugby players during the tournament. For example, it is known that athletes, who train hard 
and then participate in strenuous competition, have increased respiratory tract symptoms (runny 
nose, sore throat, sinusitis, enlarged lymph glands in the neck, and even cough and chest pain 
with fever and headaches). However, these symptoms may not always be due to an infection but 
could be as a result of allergies or pollution. It has also been shown that apart from respiratory 
tract illness, other illnesses are very most common during competitions such as at the Olympic 
Games. These illnesses include gastro-intestinal symptoms, allergies, skin conditions, and other 
infections. These patterns of illness have not been studied in rugby players, particularly during 
competitions.  
 
You will be given an opportunity to participate in a study where this will be investigated in rugby 
players. In the period prior to the competition, the UCT Research Office will provide your team 
doctor with all the information regarding the study. Your team doctor will then give you 
information about the study. You will then be given the opportunity to volunteer to participate in 
the study.  
 
The details of the study are as follows: 
 Your team doctor will give you a medical questionnaire that can be completed with the team 
doctor. This medical questionnaire will be anonymous and only a coding system will be used 
to identify your team. Your personal details will not be on the form. The questionnaire deals 
with training information and medical information.  
 At the time of the competition, your team doctor will ask you every day about possible 
medical conditions and injuries. This information will be recorded anonymously on a sheet 
which will be sent to the investigators. If you suffer form any injury or disease/condition, your 
team doctor will treat it in the usual fashion. 
 
Potential risks of this study  
 The completion of a questionnaire is not associated with any risk. Questionnaire and other 
clinical data (paper and electronic) will be kept confidential, will be kept secure, and will not 
be made available to any party other than the research team without the consent of the 
individual participants. 
 All medical conditions will be treated by the team doctor.  
 




 The anticipated benefits of this study are that the results will further our understanding of the 
possible cause/s of medical conditions in rugby players that travel to participate in 
international competitions.  
 
As a participant in the 2010 Super 14 Rugby tournament, you are given the choice to participate 
in this research effort. Your participation is entirely voluntary. Please read through the details of 
the study. The details of the study are explained in this document, and if you wish to participate 
in the study, please read through and sign the INFORMED CONSENT FORM on the next page. 
Please feel free to contact your team doctor, the UCT Research Office or members of the 
research team should you have any questions related to the study. Your team doctor has the 
contact details of the UCT Research Office and the research team. You can also call the 
following number of the principle investigator Prof Martin Schwellnus (+27-83-4543783) or co-
investigator Prof Wayne Derman (+27-83-4543784) 
 





I understand that a study will be conducted by the UCT/MRC Research Unit for Exercise Science 
and Sports Medicine (University of Cape Town): 
 
“Illness In Elite Rugby Players During The 2010 Super 14 Rugby tournament: A Pilot 
Study“ 
 
I understand that my participation in this research project has no direct benefits to me during the 
2010 Super 14 Rugby tournament.  However, I understand that my participation in the research 
project will advance the medical and scientific knowledge related to rugby. Therefore, information 
gathered through my participation in this project could advance the future medical care, training 
advice and performance of rugby players. 
 
I have read the study information and understand that the study involves the following 
components: 
 
Completion of a medical questionnaire before the tournament:  
 
The questionnaire will not contain any personal particulars (name, contact details). The 
completion of the questionnaire is not associated with any risk.  All the questionnaire data and 
other clinical data (paper and electronic) will be kept confidential, will be kept secure, and will not 
be made available to any party other than the research team without the consent of the individual 
subjects. 
 
I agree that all the information, which will be collected by my team doctor before the tournament, 
may be used to answer scientific questions about the medical conditions associated with the 
participation in and completion of a rugby tournament. 
 
Daily information during the rugby tournament  
 
I agree that all the information, which will be collected by my team doctor on a daily basis during 
the tournament, may be used to answer scientific questions about the medical conditions and 





I have read (or, where appropriate, have had read to me) and understood the information about this study, 
and any questions I have asked have been answered to my satisfaction.  I agree to participate in the study.  
I agree that research data provided by me or with my permission during the study may be included in a 
thesis, presented at conferences and published in journals on the condition that neither my name nor any 
other identifying information is used. 
 
I have read the preceding subject information sheet and understand the testing procedures outlined therein 
and I hereby consent to participate in this study. I understand that I may withdraw from this study at any 
time without further question.  I have been informed that the individual data derived from my participation in 
these protocols will remain confidential. I understand that the medical staff and the research team have 
professional medical insurance. 
 
Player accreditation number:  
    
Name of the team doctor:   
  
 
Signature of the player 
 
 








Signature of the Investigator: Date: 
     





Section A: Basic player details 
Team       
Player number       
Height       
Weight       cm 
Dominant Hand       kg 
Age (on first 
day of 
competition) 
       yrs 
Player position 









Section B. Training history 
On average, how many days a week did you train during 15 weeks 
before the competition (from 1st November 2009)? 
 days/wk 
On average, how many hours a week did you train in an average week 
during the 15 weeks before the competition (from 1st November 
2009)? 
 hrs/wk 
Please indicate what types of training 
you perform and the percentage of 
training during 15 weeks before the 
competition (from 1st November 
2009)?  
 Rugby training on the pitch                              
___ % 
 Strength training in a gymnasium                     
___ %  
 Endurance training (running, jogging, cycling) 
___ % 
 Flexibility / agility training                                  
___ % 
 Other training ________________                   
___ % 
On average, how many days a week did you train during 2 weeks before 
the competition (from 1 February 2010)? 
 days/wk 
On average, how many hours a week did you train in an average week 
during the 2 weeks before the competition (from 1 February 2010)? 




Please indicate what types of training 
you perform and the percentage of 
training during 2 weeks before the 
competition?  
 Rugby training on the pitch                              
___ % 
 Strength training in a gymnasium                     
___ %  
 Endurance training (running, jogging, cycling) 
___ % 
 Flexibility / agility training                                  
___ % 
 Other training ________________                   
___ % 
How did your training commitment affect your social life? 
 Not at all  
 A fair 
amount  






Section C. History of medication and supplement use 
What medication, if any, are 
you currently using? (please 
list) 
Name of medication Years taken 
            
            
            
            
Are you currently taking dietary supplements/vitamins? Yes  No  
If yes to the above question, 
please list names of dietary, 
sports or vitamin 
supplements. 
Name of supplement 
Years 
taken 
 Multi-vitamins     _____ 
 Anti-oxidants     _____ 
 Immune boosters     _____ 
 Protein powders/supplements, Protein bars. BCAAs 
 _____ 
 Creatine       _____ 
 Caffeine      _____ 
 Fat cutters      _____ 
 Carbohydrate drinks/powders/gels  
 _____ 
 Other: _____________________________ 
 _____ 
Lifestyle and habits history 
Please indicate your smoking 
status Current smoker   Ex smoker   
Never smoked  
 
If you answered 
yes, (past or 
current smoker) 
please complete 
the section on 
the right 
Number of years of smoking: 
      
If stopped, how many years ago: 
      




On average, how much alcohol do you drink per 
week (tots, glasses) of spirits, wine or beer? 
_______  glasses beer/cider per 
week 
_______  glasses wine per week 





Section D. Family medical history 
Have any of your blood (biological) relatives ever had the following?  
Please tick yes or no. If yes, please tick the relationship of that person to you (You 
may tick more than one of the relationship blocks).  
Description  If Yes, please indicate the relationship  
Asthma 
Yes 
 No  
 Father      Mother         Brother   
  Sister    Child 
 Grandfather   Grandmother  
Allergies (in general) 
Yes 
 No  
 Father      Mother         Brother   
  Sister    Child 






Section E. General personal medical history 
In this section, you are asked to read through 8 questions about your personal general 
medical history. If you answer “yes” to any of questions, please complete the additional 
questions about that symptom/condition.  
Question 1: Please indicate if you had any of the following immunizations 
Influenza (H1N1)                                Yes  No 
 
Measles / Mumps / Rubella            Yes  
No  
Chicken Pox (Varicella)                      Yes  No 
 
Meningitis (Menimune/Menactra)   Yes  
No  
Hepatitis A (2 injections)                     Yes  No 
 
Tetanus / Diptheria                         Yes  
No  
Hepatitis B (3 injections)                     Yes  No 
 
Yellow fever                                    Yes  
No  
Other immunizations? Yes  No  Please give details:  
Are you taking malaria prophylaxis (tablets) Yes  
No  
If yes, which tablets: 
Question 2: Recent close contact with individuals who had “flu” symptoms  
 
(fever, sore throat, blocked or runny nose, cough, wheeze, muscle aches 
and pains) 
2a. In the 6 weeks before the competition (from 1st January 2010) did you 
have any close contact (body contact, hand shakes, close spaces where 
coughing and sneezing occurred < 1 meter from you) with individuals who 
suffered from any symptoms of flu? 
Yes 
 No  
2b. In the last week before the competition (from 4th February 2010) did 
you have any close contact (body contact, hand shakes, close spaces where 
coughing and sneezing occurred < 1 meter from you) with individuals who 
suffered from any symptoms of flu? 
Yes 
 No  
Question 3: Flu symptoms in the last week before the competition  
(from 4th February 2010) 
3a. In the last week (from 4th February 2010) before the competition did 
you suffer from any symptoms of flu (fever, sore throat, blocked or runny 
nose, cough, wheeze, muscle aches and pains)? 
Yes 




If you answered NO to question 3a – Please go to Question 4 below 
If you answered YES to question 3b - please complete the following additional questions 
(3b) Please tick which of these 
flu symptoms you suffered 
from in the last week. 
 Fever   Cough  Joint pains 
 Blocked nose   Wheezing  Sore Throat 
 Runny nose   Muscle aches 
 Any other flu symptoms   
      (Specify: _____________________________) 
Question 4: Flu symptoms in the 6 weeks before the competition  
(from 1st January 2010) 
4a. In the last 6 weeks (from the 1st January 2010) before the 
competition (did you suffer from any symptoms of flu (fever, sore throat, 
blocked or runny nose, cough, wheeze, muscle aches and pains)? 
Yes 
 No  
If you answered NO to question 4a – Please go to Question 5 below 
If you answered YES to question 4a - please complete the following additional questions 
(4b) Please tick which of these 
flu symptoms you suffered 
from in the last 6 weeks. 
 Fever   Cough  Joint pains 
 Blocked nose   Wheezing  Sore Throat 
 Runny nose   Muscle aches 
 Any other flu symptoms   
      (Specify: _____________________________) 
Question 5: History of allergy symptoms 
5a. Have you ever in your rugby career suffered from symptoms of allergies 
including nose allergies (hay fever), allergic sinusitis, allergic asthma, skin 
allergies, a past history of allergies to medication, plant material or animal 
material? 
Yes 
 No  
If you answered NO to question 5a – Please go to Question 6 below 
If you answered YES to question 5a - please complete the following Table 
5b. Please indicate how long (years) have you been suffering from 
allergies? 
        years 
5c. Please tick which type of allergy do you currently suffer from 
Nose (hay 
fever) 
Yes  No 
 Sinusitis Yes  No  
Asthma 





Yes  No 




Yes  No  
Allergy to 
foods 
Yes  No 
 
Allergy to 
animals Yes  No  
Allergy to 
medication Yes  No  
5d. Please tick which type of allergy do you currently take medication for 
Nose (hay 
fever) 
Yes  No 
 Sinusitis Yes  No  
Asthma 
(allergic) Yes  No  
Skin allergies 
Yes  No 




Yes  No  
Allergy to 
foods 
Yes  No 
 
Allergy to 
animals Yes  No  
Allergy to 
medication Yes  No  
5e. Please tick which type of medication do you currently take 
Cortisone 
nose spray 
Yes  No 
 
Cortisone nose 




Yes  No  
Cortisone 
cream 
Yes  No 
 
Anti-histamine 





Yes  No  
5f. Please tick which symptoms of allergy do you currently suffer from  
Sneezing 
Yes  No 
 
Itchy runny 
nose Yes  No  Headache Yes  No  
Itchy palate 
Yes  No 
 
Streaming 
eyes Yes  No  Fatigue Yes  No  
Itchy eyes 
Yes  No 
 Blocked nose Yes  No  Poor sleep Yes  No  
Post nasal 
drip 
Yes  No 
 Coughing Yes  No  Wheezing Yes  No  
In which months of the year 
do you currently have 
symptoms of allergies? (You 
tick more than one) 
 Jan   Feb     March    April  May     
June    




5g. Please tick which type of allergy did you suffer from in the past (NOT currently) 
Nose (hay 
fever) 
Yes  No 
 Sinusitis Yes  No  
Asthma 
(allergic) Yes  No  
Skin allergies 
Yes  No 




Yes  No  
Allergy to 
foods 
Yes  No 
 
Allergy to 
animals Yes  No  
Allergy to 
medication Yes  No  
 
Question 6: History of asthma 
6a. Do you currently suffer from asthma including exercise induced asthma, 
or symptoms of asthma such as shortness of breath, wheezing, or chronic 
coughing? 
Yes 
 No  
If you answered NO to question 6a – Please go to Question 7 below 
If you answered YES to question 6a - please complete the following questions 
6b. How many years have you suffered from asthma?        (years) 
6c. How was your 
asthma diagnosed?  
 A doctor taking a history and performing an examination 
 Lung function test (blow test) but no exercise 
 Lung function test (blow test) before and after exercise 
 Metacholine challenge test 
 Eucapnic hyperventilation test (rebreathing test) 
 Other test  (Specify:  ________________________) 
6d. Which type of 
asthma do you currently 
suffer from? 
 Asthma that occurs at any time but not during exercise 
 Asthma that occurs at any time including during exercise 




6e. Please indicate how 
frequently do you 
currently experience 
the symptoms of 
asthma (shortness of 
breath, wheezing, 
coughing or coughing 
after exercise)? 
Daytime symptoms (per week) 
 < 2 / week       2-4 / week        >4 / week          All the 
time 
Night time symptoms (per month) 
 < 1 / month       2-3 / month        >4 / month        All the 
time 
Exercise related symptoms (per 10 exercise sessions) 
 <1 per 10 sessions    2-3 per 10 sessions    >4 per 10 
sessions 
6f. Please indicate if you 
had symptoms of asthma 
that were severe enough 
to necessitate hospital 
admission in the last 12 
months 
 No hospital admission for asthma in the last 12 months  
 1-2 hospital admissions for asthma in the last 12 months  
 3-4 hospital admissions for asthma in the last 12 months  
 >4 hospital admissions for asthma in the last 12 months  
6g. Which symptoms of 
asthma do you currently 
suffer from? 
 Wheezing   Dry cough   Shortness of breath 
 Tight chest   Chest pain  




6h. What medication do 
you currently use for 
your asthma? (you may 
tick more than one 
option) 
 Cortisone inhaler (e.g. Beclate, Becloforte, Becodisks, Becotide, 
Budeflam, Flixotide, Inflammide, Pulmicort, Qvar, etc)   
 Salbutamol (bronchodilator) inhaler (e.g. Ventolin, Venteze, 
Vomax, Airomir, Asthavent etc.) 
 Salmeterol (bronchodilator) inhaler (Serevent) 
 Fenoterol (bronchodilator) inhaler (Berotec) 
 Terbutaline (bronchodilator) inhaler (Bricanyl) 
 Formoterol (bronchodilator) inhaler (e.g. Foradil, Foratec, Oxis) 
 Ipratropium (bronchodilator) inhaler (Atrovent) 
 Tiotropium (bronchodilator) inhaler (Spiriva) 
 Combined cortisone and bronchodilator  inhaler (e.g. Atrovent, 
Berodual, Combivent, Duolin, Duovent, Seretide, Symbicord)  
 Cortisone tablets 
 Bronchodilator tablets 
 Leukotriene receptor antagonist tablets (e.g. Acccolate, 
Singulair) 
 Other inhaler  
 Other medication (Specify: ________________________) 
6i. When do you use 
your medication for your 
asthma? 
 Daily (irrespective of exercise)  Only before exercise 
 Other (Specify: ________________________) 
6j. How long before an exercise session do you use your medication for 
asthma? 
      min 
6k. Have you obtained TUE (therapeutic use exemption forms) for your 
asthma medication? 
Yes  No  
 
 




7a. Have you ever in your rugby career suffered from muscle cramping 
(painful, spontaneous, sustained spasm of a muscle) during or immediately 
(within 6 hours) after exercise (in training or competition)?  
Yes 
 No  
If you answered NO to question 7a – Please go to Question 8 below 
If you answered YES to question 7a - please complete the following additional questions 
7b. For how many years have you suffered from cramping?        (years) 
7c. Did you suffer from cramping during or after exercise in the last 12 
months? 
Yes  No  
7d. With what type of training is your cramping 
associated (You can tick more than one form of 
exercise)? 
 Rugby    Weight training 
 Running   Other 
7e. In the last 10 matches or training sessions, 
how many times have you experienced cramping? 
Matches:  _____/10 
Training sessions:  _____/10 
7f. What treatment/s have you had 
that successfully relieved an acute 
cramp? (can tick more than one) 
 Stretching        Resting  
 Drinking fluid  Ice application 
 Massage        Magnesium 
 Salt (tablets or solution) 
 Other  (Specify: 
_____________________________) 
7g. At what point in the competition 
or training session do you usually 
first experience cramping? 
 First quarter   Second quarter  
 Third quarter  Fourth quarter 
 After the session   No pattern 
7h. In which muscles do you usually 
cramp (please list the muscle by the 
one which cramps most frequently (as 
1) and the others after that (2-4)? 
 Calves   Hamstrings  
 Quadriceps (thigh)  Foot muscles 
 Other  (Specify: 
_____________________________) 
7i. Have you ever suffered from cramping in your whole body (arms and 
legs)? Yes  No  
7j. Have you ever been admitted to hospital following cramping? Yes  No  
7k. Have you ever been confused or in a coma during or after a cramping 




7l. Have you ever had “dark urine” in the 3 days following a cramping 
episode? Yes  No  
7m. If you cramp, how long does the cramp usually last for (min)?      (minutes) 
7n. If you cramp, how severe is the cramp usually? 
(please tick). 
 Mild: < 5 minutes and you are able 
to continue exercising 
 Moderate: 5-15 minutes and you are 
able to continue exercising 
 Severe: >15 minutes or if  you have 
to STOP exercising 
 
 
Question 8: History gastro-intestinal symptoms during rugby 
8a. Have you ever in your rugby career suffered gastrointestinal symptoms 
during rugby including heartburn, nausea, vomiting, abdominal pain, urge to 
defecate (pass a stool), diarrhoea, or blood in the stools? 
Yes 
 No  
If you answered NO to question 8a – Please go to Question 9 below 
If you answered YES to question 8a - please complete the following Table 
Symptom 
Number of times 
you experienced 
the GIT 
symptom in the 




Number of times 
you experienced 
the GIT symptom in 
the last 10 matches 
(during rugby 
matches) 
Please indicate the “severity” of the GIT symptom during 
training or playing rugby 
Nausea        
 Does not affect training or playing 
 Affects training/playing rugby (slow down or reduce time) 
 Prevents training/playing rugby 
Vomiting             
 Does not affect training or playing 
 Affects training/playing rugby (slow down or reduce time) 
 Prevents training/playing rugby 
Heartburn             
 Does not affect training or playing 
 Affects training/playing rugby (slow down or reduce time) 




Abdominal pain             
 Does not affect training or playing 
 Affects training/playing rugby (slow down or reduce time) 
 Prevents training/playing rugby 
Urge to pass a 
stool (defecate)             
 Does not affect training or playing 
 Affects training/playing rugby (slow down or reduce time) 
 Prevents training/playing rugby 
Diarrhoea             
 Does not affect training or playing 
 Affects training/playing rugby (slow down or reduce time) 
 Prevents training/playing rugby 
Passing blood 
in the stool                  
 Does not affect training or playing 
 Affects training/playing rugby (slow down or reduce time) 
 Prevents training/playing rugby 
Please indicate if you previously suffered from 
or had any of the following (you may tick more 
than one)? 
 History of heartburn  
 Gastroscopy 
 Ulcer (gastric, duodenal) 
 Irritable bowel syndrome 
 Allergy to milk products 
 Other past history of GIT disease 
 
 
Question 9: History of nervous system symptoms during rugby 
9a. Have you ever in your rugby career suffered from symptoms of the 
nervous system including exercise induced headaches, depression, anxiety, 
nerve tingling or loss of sensation? 
Yes 
 No  
If you answered NO to question 9a – Please go to Question 10 below 





Number of times in 




Number of times 
in last 10 races  
(during rugby 
matches) 
Please indicate the “severity” of the symptom during training 
or playing rugby 
Headaches             
 Does not affect training or playing 
 Affects training/playing rugby (slow down or reduce time) 
 Prevents training/playing rugby 
Depression   
 Does not affect training or playing 
 Affects training/playing rugby (slow down or reduce time) 
 Prevents training/playing rugby 
Anxiety   
 Does not affect training or playing 
 Affects training/playing rugby (slow down or reduce time) 
 Prevents training/playing rugby 
Nerve tingling 
in the hands             
 Does not affect training or playing 
 Affects training/playing rugby (slow down or reduce time) 




            
 Does not affect training or playing 
 Affects training/playing rugby (slow down or reduce time) 
 Prevents training/playing rugby 
Nerve tingling 
in the feet             
 Does not affect training or playing 
 Affects training/playing rugby (slow down or reduce time) 




            
 Does not affect training or playing 
 Affects training/playing rugby (slow down or reduce time) 
 Prevents training/playing rugby 
 




10a. Did you suffer from any skin 
disease in the last year? 
Skin infections:             Yes 
Skin allergy:                  
Yes   Sunburn:           
             Yes  
Skin cancer:                  Yes 
Other skin damage 
resulting from sun exposure:       
Yes  
10b. Did you suffer from any 
blood disorder in the last 
year? 
Anaemia:                       Yes 
Sickle cell trait:              
Yes Bleeding disorder:         
Yes  Blood clot 
(thrombosis) Yes  Other 
blood disorder:    Yes  
Low iron stores:             
Yes Sickle cell disease:        
Yes Clotting disorder:           
Yes  Blood clot (embolus)     
Yes  
Details: 
10c. Did you suffer from any 
immune system disorder in the 
last year?  
Recurrent infections:     Yes 
Leukaemia:                    
Yes  
HIV/ AIDS:             Yes 
Other immune disorder: 
Details: 
10d. Did you suffer from any 
kidney or bladder disease in 
the last year?  
Blood in urine:               Yes 
Kidney stones:               
Yes Burning urination:          
Yes  Other kidney 
disorder:   Yes  
Loin pain:                       Yes 
 
Frequent urination:        Yes 
Bilharzia infection:         
Yes  Details:  
10e. Did you suffer from any 
metabolic or hormonal disease 
in the last year?  
Diabetes mellitus:          Yes 
 Other hormone or 
metabolic disease:                         
Yes  
Thyroid disease:            Yes 
 
10f. Did you suffer from any 
symptoms (not related to an 
injury) of arthritis in the last 
year? 
Joint pain:                     Yes 
Joint redness:               
Yes Gout:                             
Yes  
Joint swelling:                Yes 
Joint stiffness:               
Yes  Other joint disorder:       
Yes  
10g. Were you born without, or 
are you missing any organs?   
Missing kidney:              Yes 
Missing testicle:             
Yes Gout:                             
Yes  
Missing eye:                  Yes 
Other missing organs:   
Yes  
10h. Do you have a history of an 
injury to any vital internal 
organs?  
Liver injury:                    Yes 
Spleen injury:                
Yes Heart injury:                   
Yes  
Kidney injury:                 Yes 
Lung injury:                    





10i. Do you have any other 








Appendix B: Informed Consent Form 
 
STUDY INFORMATION AND INFORMED CONSENT 
A research study will be conducted to determine how common medical conditions and illness are in players who 
participate in the 2010 Super 14 Rugby tournament in February to May 2010. This tournament will be held at venues 
in South Africa, New Zealand and Australia. The detailed information on each of the components of the study is as 
follows:  
The purpose of this study is to determine how common a variety of medical conditions and illness are in 
rugby players during the tournament. For example, it is known that athletes, who train hard and then 
participate in strenuous competition, have increased respiratory tract symptoms (runny nose, sore throat, 
sinusitis, enlarged lymph glands in the neck, and even cough and chest pain with fever and headaches). 
However, these symptoms may not always be due to an infection but could be as a result of allergies or 
pollution. It has also been shown that apart from respiratory tract illness, other illnesses are very most 
common during competitions such as at the Olympic Games. These illnesses include gastro-intestinal 
symptoms, allergies, skin conditions, and other infections. These patterns of illness have not been studied 
in rugby players, particularly during competitions.  
 
You will be given an opportunity to participate in a study where this will be investigated in rugby players. 
In the period prior to the competition, the UCT Research Office will provide your team doctor with all the 
information regarding the study. Your team doctor will then give you information about the study. You 
will then be given the opportunity to volunteer to participate in the study.  
 
The details of the study are as follows: 
 Your team doctor will give you a medical questionnaire that can be completed with the team doctor. 
This medical questionnaire will be anonymous and only a coding system will be used to identify your 
team. Your personal details will not be on the form. The questionnaire deals with training information 
and medical information.  
 At the time of the competition, your team doctor will ask you every day about possible medical 
conditions and injuries. This information will be recorded anonymously on a sheet which will be sent 
to the investigators. If you suffer from any injury or disease/condition, your team doctor will treat it in 





Potential risks of this study  
 The completion of a questionnaire is not associated with any risk. Questionnaire and other clinical data 
(paper and electronic) will be kept confidential, will be kept secure, and will not be made available to 
any party other than the research team without the consent of the individual participants. 
 All medical conditions will be treated by the team doctor.  
 
Potential benefits of this study 
 The anticipated benefits of this study are that the results will further our understanding of the possible 
cause/s of medical conditions in rugby players that travel to participate in international competitions.  
 
As a participant in the 2010 Super 14 Rugby tournament, you are given the choice to participate in this 
research effort. Your participation is entirely voluntary. Please read through the details of the study. The 
details of the study are explained in this document, and if you wish to participate in the study, please read 
through and sign the INFORMED CONSENT FORM on the next page. Please feel free to contact your 
team doctor, the UCT Research Office or members of the research team should you have any questions 
related to the study. Your team doctor has the contact details of the UCT Research Office and the research 
team. You can also call the following number of the principle investigator Prof Martin Schwellnus (+27-
83-4543783) or co-investigator Prof Wayne Derman (+27-83-4543784) 
 
University of Cape Town Research Ethics approval number: REC REF 004/2010 
 
 
I understand that a study will be conducted by the UCT/MRC Research Unit for Exercise Science and 
Sports Medicine (University of Cape Town): 
 
“Illness In Elite Rugby Players During The 2010 Super 14 Rugby tournament: A Pilot Study“ 
 
I understand that my participation in this research project has no direct benefits to me during the 2010 
Super 14 Rugby tournament.  However, I understand that my participation in the research project will 
advance the medical and scientific knowledge related to rugby. Therefore, information gathered through 
my participation in this project could advance the future medical care, training advice and performance of 
rugby players. 
 





Completion of a medical questionnaire before the tournament:  
 
The questionnaire will not contain any personal particulars (name, contact details). The completion of the 
questionnaire is not associated with any risk.  All the questionnaire data and other clinical data (paper and 
electronic) will be kept confidential, will be kept secure, and will not be made available to any party other 
than the research team without the consent of the individual subjects. 
 
I agree that the all the information, which will be collected by my team doctor before the tournament, may 
be used to answer scientific questions about the medical conditions associated with the participation in and 
completion of a rugby tournament. 
 
Daily information during the rugby tournament  
 
I agree that the all the information, which will be collected by my team doctor on a daily basis during the 
tournament, may be used to answer scientific questions about the medical conditions and injuries that are 
associated with the participation in and completion of a rugby tournament.   
 
I have read (or, where appropriate, have had read to me) and understood the information about this study, and any 
questions I have asked have been answered to my satisfaction.  I agree to participate in the study.  I agree that 
research data provided by me or with my permission during the study may be included in a thesis, presented at 
conferences and published in journals on the condition that neither my name nor any other identifying information is 
used. 
 
I have read the preceding subject information sheet and understand the testing procedures outlined therein and I 
hereby consent to participate in this study. I understand that I may withdraw from this study at any time without 
further question.  I have been informed that the individual data derived from my participation in these protocols will 
remain confidential. I understand that the medical staff and the research team have professional medical insurance. 
 
Player accreditation number:  
    
Name of the team doctor:   
  
 
Signature of the player 
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